Other diseases of blood and blood-forming organs, wide

D3_BLOODOTHER

hematologic disease: A disease involving the hematopoietic system.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints D3_AGRANULOCYTOSIS D3_FUNCPOLYMORPHONUCNEUTRO D3_OTHERWHITECELL D3_SPLEENDISEASE D3_METHAEMOGLOBINAEMIA D3_OTHERBLOOD D3_OTHDISLYMPHORETANDRETICULOHIST D3_BLOODINOTH	10044
6. Filter based on genotype QC (FinnGen only)	9717

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF12

NAME	D3_BLOODOTHER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	D3_AGRANULOCYTOSIS\|D3_FUNCPOLYMORPHONUCNEUTRO\|D3_OTHERWHITECELL\|D3_SPLEENDISEASE\|D3_METHAEMOGLOBINAEMIA\|D3_OTHERBLOOD\|D3_OTHDISLYMPHORETANDRETICULOHIST\|D3_BLOODINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of blood and blood-forming organs, wide based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	61862	33444	27962
Only index persons	52577	29034	23543
Unadjusted period prevalence (%)
Whole population	0.87	0.96	0.78
Only index persons	0.99	1.07	0.90
Median age at first event (years)
Whole population	59.66	59.54	59.73
Only index persons	58.81	58.55	59.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9717	5469	4248
Unadjusted period prevalence (%)	1.94	1.94	1.95
Median age at first event (years)	60.00	57.47	63.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10044: Matched controls
100436

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A41.9

ICD-10 Finland

Sepsis, unspecified

5.1

316.7

703

1468

M04AA01

ATC

allopurinol; systemic

2.8

310.3

1840

7416

H02AB02

ATC

dexamethasone; systemic

4.9

307.7

2509

6379

L03AA02

ATC

filgrastim; parenteral

10.7

307.7

1073

1113

D75.1

ICD-10 Finland

Secondary polycythaemia

318.0

307.7

845

D75.2

ICD-10 Finland

Essential thrombocytosis

429.4

307.7

970

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.0

307.7

1236

1980

D75.0

ICD-10 Finland

Familial erythrocytosis

192.6

307.7

189

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

120.7

307.7

327

D70.89

ICD-10 Finland

Neutropenic splenomegaly

701.7

307.7

1974

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

12.9

307.7

683

565

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

40.9

307.7

644

168

A04AA01

ATC

ondansetron; systemic, rectal

4.2

307.7

1565

4230

115

Kela drug reimbursment

Breast cancer

3.4

307.7

1325

4321

JN4BD

NOMESCO Finland

Extensive body CT

3.9

307.7

1952

5823

A04AD12

ATC

aprepitant; systemic

7.0

307.7

510

758

D72.1

ICD-10 Finland

Eosinophilia

617.7

307.7

582

L03AA13

ATC

pegfilgrastim; parenteral

8.6

307.7

1384

1826

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.7

307.7

2663

5950

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

427.4

307.7

788

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

5934

34388

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.4

307.7

1005

1710

D70.82

ICD-10 Finland

Drug-induced neutropenia

3883.7

307.7

2801

JN4AD

NOMESCO Finland

Body CT examination

3.3

307.7

1671

5673

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

307.7

2347

7843

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

14.0

307.7

390

288

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

70.5

307.7

261

R50.9

ICD-10 Finland

Fever, unspecified

4.0

307.7

2784

8813

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

8.5

307.7

442

544

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

8.4

307.7

677

856

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

284.3

307.7

1224

A04AA02

ATC

granisetron; systemic, transdermal

5.3

307.7

1473

3137

J01MA12

ATC

levofloxacin; systemic

2.7

307.7

2580

11473

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

307.7

3633

13974

ZX120

NOMESCO Finland

Intravenous

3.9

307.7

1731

5122

L03AA14

ATC

lipegfilgrastim; parenteral

8.6

307.7

576

707

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

17.0

307.7

2201

1634

XW000

NOMESCO Finland

Bone marrow biopsy

19.5

307.7

2339

1536

L01XX05

ATC

hydroxycarbamide; oral

32.2

307.7

846

286

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

24.4

307.7

621

270

WW500

NOMESCO Finland

Blood transfusion

8.5

307.7

1247

1648

N02AA05

ATC

oxycodone; systemic

2.6

307.7

2381

10573

D45

ICD-10 Finland

Polycythaemia vera

18.2

307.7

420

240

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

11.7

307.7

456

406

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

31.4

307.5

200

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

4.2

305.8

882

2268

Z51.5

ICD-10 Finland

Palliative care

3.3

293.8

1219

4003

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.3

292.9

358

399

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

17.1

291.7

242

145

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.3

291.4

617

1235

L01XX35

ATC

anagrelide; oral

85.7

288.1

152

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

288.0

1378

4923

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

285.0

3978

23384

ZX112

NOMESCO Finland

Subcutaneous

6.2

271.9

479

807

A04AA55

ATC

palonosetron, combinations; systemic

4.6

268.6

667

1525

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

258.3

1478

5806

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

253.2

2955

16044

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

11.6

253.0

262

231

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

21.4

252.9

189

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.6

251.9

900

2678

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

240.2

2112

10164

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

239.5

4152

26014

D73.5

ICD-10 Finland

Infarction of spleen

+∞

233.2

223

JN6AD

NOMESCO Finland

CT of torso and neck

6.8

233.1

372

566

D69.5

ICD-10 Finland

Secondary thrombocytopenia

23.3

226.0

163

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

4.1

216.4

625

1600

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

215.9

927

3086

H02AB06

ATC

prednisolone; systemic

1.9

213.5

5184

35959

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.4

210.4

234

229

XX3DW

NOMESCO Finland

Time consuming IT work

2.6

210.0

1439

6149

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.4

205.9

776

2382

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.1

203.9

588

1503

HAC20

NOMESCO Finland

Total mastectomy

3.8

203.4

649

1783

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3.9

197.2

613

1653

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

194.5

2538

14153

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.0

193.9

953

3423

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.0

192.3

918

3243

A02BC02

ATC

pantoprazole; systemic

1.9

191.8

7114

55723

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

187.5

473

1091

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

6.8

187.5

299

454

HA1AA

NOMESCO Finland

X-ray mammography

2.8

187.3

1045

4017

TPH00

NOMESCO Finland

Phlebotomy

13.9

185.9

172

126

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.9

184.8

576

1555

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

14.0

178.2

164

119

C03CA01

ATC

furosemide; systemic

1.9

177.8

3173

19607

C83.1

ICD-10 Finland

Mantle cell lymphoma

17.0

176.2

146

TGC00

NOMESCO Finland

Bronchial lavation

4.5

176.1

444

1023

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

14.8

175.0

156

107

SPAT1074

SPAT

Venesection

15.0

174.2

154

104

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

171.9

662

2055

B01AB05

ATC

enoxaparin; parenteral

1.9

171.8

3451

22095

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

3.1

171.6

793

2745

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

25.4

169.1

118

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.0

168.4

807

2851

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

167.9

3194

20072

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

5.6

167.8

324

594

L02BA01

ATC

tamoxifen; oral

3.5

165.8

605

1814

B01AB10

ATC

tinzaparin; parenteral

2.4

158.4

1241

5597

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.6

158.0

978

3950

WW300

NOMESCO Finland

Transfer of autologic stem cells

14.7

157.8

141

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

157.8

519

1452

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

157.6

994

4051

D73.1

ICD-10 Finland

Hypersplenism

526.2

157.2

156

L02BG04

ATC

letrozole; oral

2.7

151.8

885

3466

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.9

150.9

768

2800

ZX108

NOMESCO Finland

Inhalation

9.0

150.3

186

210

B03XA02

ATC

darbepoetin alfa; parenteral

4.6

148.1

359

801

WZC30

NOMESCO Finland

Teaching

2.0

147.5

1817

9803

127

Kela drug reimbursment

Transplant complication

5.4

144.3

288

544

J01MA14

ATC

moxifloxacin; systemic

2.4

144.0

1095

4863

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

13.0

141.7

136

106

D75.8

ICD-10 Finland

Other specified diseases of blood and blood-forming organs

183.9

138.9

145

130

Kela drug reimbursment

Malignant tumour

2.4

136.9

1072

4818

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

3.4

136.9

507

1532

L03AB05

ATC

interferon alfa-2b; parenteral

13.2

134.8

128

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

17.8

134.5

109

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.0

132.9

181

230

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.6

132.3

451

1291

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

130.7

264

504

R72

ICD-10 Finland

Abnormality of white blood cells, not elsewhere classified

13.4

130.4

123

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

28.3

129.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

129.2

1158

5505

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

11.4

127.7

133

118

C91.7

ICD-10 Finland

Other lymphoid leukaemia

44.4

126.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

122.8

484

1519

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.6

122.0

236

433

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.9

121.8

604

2166

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

8.4

121.5

158

190

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

120.1

2439

15353

9960/3-C42.1

ICD-O-3

Myeloproliferative neoplasm, NOS, of bone marrow

32.3

119.5

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

11.4

119.1

124

110

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

119.0

5186

39835

ZXE00

NOMESCO Finland

One hour or less

1.6

117.2

3883

27843

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

17.8

117.2

H02AB09

ATC

hydrocortisone; systemic

3.8

117.0

365

983

X76

ICPC

Malignant neoplasm breast female

4.2

116.9

317

771

L01BC06

ATC

capecitabine; oral

3.0

116.5

533

1827

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

116.3

647

2465

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

24.3

115.6

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.6

115.1

185

283

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

113.9

2691

17635

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.5

113.7

279

628

YNB10

NOMESCO Finland

Collection of stem cells for transplant

21.7

113.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

113.1

2116

12971

PJA12

NOMESCO Finland

Sentinel node biopsy

2.3

113.0

923

4210

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

112.2

1133

5633

B99

ICPC

Blood/lymph/spleen disease other

10.9

112.0

120

111

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.4

110.5

221

418

JN4CD

NOMESCO Finland

Very extensive body CT

3.1

110.0

493

1669

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.1

108.9

229

453

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

18.3

108.8

J01DB01

ATC

cefalexin; oral

1.8

107.4

8202

71612

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

106.8

3594

25713

Z3231

NOMESCO Finland

Registered nurse

1.7

106.7

2781

18651

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

106.1

1255

6611

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

5.1

105.9

225

449

JMA10

NOMESCO Finland

Transabdominal total splenectomy

9.1

105.7

129

143

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.5

104.4

256

576

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

21.2

104.2

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

21.2

104.2

1CD02, ,

NOMESCO Finland

6.2

104.2

179

293

174

Kela drug reimbursment

Ruxolitinib

41.6

102.9

C50.99

ICD-10 Finland

Breast, unspecified

3.3

100.8

384

1179

374

Kela drug reimbursment

Ruxolitinib

45.6

100.0

L04AA06

ATC

mycophenolic acid; systemic

4.0

99.3

288

736

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.1

99.1

282

711

L01BB05

ATC

fludarabine; systemic

33.4

98.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

97.1

1249

6763

212

Kela drug reimbursment

Gout

4.0

96.9

279

709

L01EJ01

ATC

ruxolitinib; oral

55.3

96.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

96.7

1100

5701

L02BG06

ATC

exemestane; oral

4.2

96.2

262

639

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

10.2

96.1

108

107

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.1

95.7

267

663

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

95.5

1210

6515

L03AB04

ATC

interferon alfa-2a; parenteral

23.2

95.5

ZX121

NOMESCO Finland

Central venous catheter

10.0

94.9

108

109

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

94.9

1717

10360

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

93.7

1032

5283

1XC02, ,

NOMESCO Finland

6.8

93.3

146

217

ZX080

NOMESCO Finland

Image guided radiotherapy

3.7

93.2

308

862

WW200

NOMESCO Finland

Immunization

3.3

92.9

362

1127

R4110

NOMESCO Finland

Physiotherapy

1.6

92.7

2757

18995

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

7.0

92.4

141

204

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

19.9

92.2

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

91.8

675

2933

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

9.4

91.5

109

117

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

3.3

91.2

355

1104

L01CB01

ATC

etoposide; systemic

8.0

91.0

123

155

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

90.8

658

2840

D73.9

ICD-10 Finland

Disease of spleen, unspecified

+∞

89.7

A41.8

ICD-10 Finland

Other specified sepsis

3.9

89.2

263

680

Z2446

NOMESCO Finland

Social worker

2.3

88.1

711

3216

WX402

NOMESCO Finland

General anaesthesia

1.7

87.9

2105

13699

189

Kela drug reimbursment

Imatinib

12.8

87.9

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.9

87.8

441

1589

J05AB11

ATC

valaciclovir; oral

1.8

87.3

1455

8546

J02AC03

ATC

voriconazole; systemic

13.6

86.9

J01MA02

ATC

ciprofloxacin; systemic

1.5

86.6

3762

28176

L01CA04

ATC

vinorelbine; systemic

5.6

86.3

166

303

390

Kela drug reimbursment

Ibrutinib

19.3

85.8

192

Kela drug reimbursment

Fulvestrant

7.8

85.6

119

155

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

32.5

85.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

10.5

84.8

Z31.5

ICD-10 Finland

Genetic counselling

2.5

84.2

568

2371

N05CF01

ATC

zopiclone; oral

1.6

83.6

3097

22351

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

15.3

83.6

L04AD02

ATC

tacrolimus; systemic

5.2

82.0

170

332

L04AD01

ATC

ciclosporin; systemic

3.7

82.0

264

726

2888B

ICD-9 Finland

Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]

+∞

81.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

4.0

81.2

231

582

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

81.0

1295

7496

ZXD05

NOMESCO Finland

Urgent procedure

1.6

80.7

2885

20623

D70.80

ICD-10 Finland

Agranulocytic angina

794.9

80.5

L02BA03

ATC

fulvestrant; parenteral

6.6

80.4

130

200

N02AX02

ATC

tramadol; systemic, rectal

1.5

80.1

4129

31900

M05BX04

ATC

denosumab; parenteral

2.3

80.1

657

2989

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

12.0

79.7

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

4.2

79.1

212

511

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

10.9

78.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

78.1

473

1875

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

77.7

1701

10768

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

77.5

3442

25738

N02BE01

ATC

paracetamol; systemic, rectal

1.8

77.3

8697

79008

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.5

77.1

125

193

A06AD11

ATC

lactulose; oral

1.8

77.0

1410

8491

1512

Kela drug reimbursment

Ibrutinib

18.6

76.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.5

76.8

271

792

N05AH02

ATC

clozapine; systemic

3.8

75.6

230

608

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

11.7

75.5

D70.81

ICD-10 Finland

Neutropenia congenital

744.0

75.3

D70

ICD-10 Finland

Agranulocytosis

375.2

74.8

NK6AN

NOMESCO Finland

Total body bone isotope imaging

3.0

74.8

341

1164

TQW20

NOMESCO Finland

Tatoe

4.9

74.6

165

341

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

10.3

73.8

128

Kela drug reimbursment

Cancers of female genital organs

3.7

73.8

239

660

B73

ICPC

Leukaemia

17.0

73.8

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

73.5

308

1001

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

72.8

666

3166

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

72.5

291

922

WF004

NOMESCO Finland

Palliative radiotherapy

3.3

72.2

273

834

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

31.5

72.2

R06.0

ICD-10 Finland

Dyspnoea

1.5

71.5

2537

18012

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

71.4

1772

11563

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

10.8

71.3

L01XX52

ATC

venetoclax; oral

17.0

71.2

WW409

NOMESCO Finland

Other aferesis

11.9

71.2

A46

ICD-10 Finland

Erysipelas

1.7

71.1

1420

8747

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

71.1

1333

8068

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

3.3

70.9

277

863

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

4.4

70.3

179

415

D73.4

ICD-10 Finland

Cyst of spleen

693.2

70.1

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.7

69.9

378

1415

L01EA01

ATC

imatinib; oral

17.4

69.6

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

8.9

69.5

L01XE01

ATC

[U] imatinib

12.4

69.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

69.1

586

2700

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

68.7

348

1258

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

68.0

3915

30608

A79

ICPC

Malignancy NOS

3.8

67.9

209

557

UJF32

NOMESCO Finland

Coloscopy

1.5

67.9

2502

17875

399

Kela drug reimbursment

Venetoclax

16.4

67.6

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

12.3

67.5

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.0

67.5

119

200

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

4.0

67.5

192

484

TPH00, ,

SPAT

20.5

67.1

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

4.2

67.0

181

439

R11

ICD-10 Finland

Nausea and vomiting

1.9

66.9

852

4568

SPAT1255

SPAT

Intravenous administration of medicine

2.1

66.6

706

3548

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

13.2

66.4

A05AA02

ATC

ursodeoxycholic acid; oral

3.7

66.4

217

603

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.6

66.3

226

646

Z3226

NOMESCO Finland

Physiotherapist

1.6

66.1

1742

11516

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.3

65.5

171

404

N05AH03

ATC

olanzapine; systemic

2.2

65.1

607

2905

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

24.3

64.7

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

8.6

64.4

ED1AA

NOMESCO Finland

Mandibular X-ray examination

6.0

64.2

114

193

C90.0

ICD-10 Finland

Multiple myeloma

4.4

64.2

161

369

Z2221

NOMESCO Finland

Medical doctor

1.5

64.1

2546

18443

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.0

64.0

285

960

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

63.1

2147

15038

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.4

62.8

234

708

L01XE27

ATC

[U] ibrutinib

27.0

62.8

1501

Kela drug reimbursment

Palbociclib

6.2

62.8

107

174

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

62.7

328

1206

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

5.0

62.7

135

273

316

Kela drug reimbursment

Imatinib

18.9

62.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

62.1

583

2796

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

19.3

61.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

61.3

813

4415

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

61.1

528

2450

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

4.5

60.9

150

339

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

9.4

60.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.0

59.9

274

937

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

10.4

59.6

TPX15

NOMESCO Finland

Removal of vascular injection port

6.5

59.4

151

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

3.1

59.4

255

841

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

58.9

428

1845

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

58.7

557

2682

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

58.5

1466

9543

28899

ICD-8 Finland

Agranulocytosis

+∞

58.4

ZY010

NOMESCO Finland

Hospital outpatient

2.2

58.0

495

2284

J01FF01

ATC

clindamycin; systemic

1.5

57.9

2499

18346

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

3.0

57.8

267

918

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

57.7

823

4574

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.9

57.4

275

965

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.6

57.3

190

533

3AA13, ,

NOMESCO Finland

10.2

57.2

D73.8

ICD-10 Finland

Other diseases of spleen

288.4

56.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.5

55.9

196

571

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

55.8

287

1046

E0000UV, ,

ATC

1.4

55.8

3810

30396

C82.1

ICD-10 Finland

Follicular lymphoma grade II

5.6

55.6

106

192

D73.0

ICD-10 Finland

Hyposplenism

551.2

55.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.1

55.4

155

386

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

14.9

55.3

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.6

55.3

183

513

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.9

55.3

122

252

B74

ICPC

Malignant neoplasm blood other

11.2

55.2

H02AB07

ATC

prednisone; oral

1.7

55.2

1276

8131

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

4.0

55.0

157

397

120

Kela drug reimbursment

Hypogammaglobulinaemia

12.0

54.8

A07AA09

ATC

vancomycin; oral

3.7

54.5

177

490

C91.4

ICD-10 Finland

Hairy-cell leukaemia

22.3

54.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

54.4

815

4597

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.0

54.2

157

401

WX892

NOMESCO Finland

Monitored bed care

1.9

54.2

733

4001

394

Kela drug reimbursment

Palbociclib

6.0

54.2

159

L01AA02

ATC

chlorambucil; oral

9.5

54.1

FM1FN

NOMESCO Finland

Heart function isotope examination

5.8

54.0

173

N03AX16

ATC

[U] pregabalin

1.5

53.7

2148

15492

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

53.4

1010

6098

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.3

53.3

108

207

HAB40

NOMESCO Finland

Wedge excision of mammary gland

2.1

53.3

512

2476

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

4.5

53.2

130

292

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

17.0

53.1

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

12.1

53.0

R4190

NOMESCO Finland

Nutritional therapy

2.4

52.8

388

1680

AA1AD

NOMESCO Finland

CT of head and brain

1.5

52.7

2473

18396

R53

ICD-10 Finland

Malaise and fatigue

1.5

52.6

2119

15297

B03XA01

ATC

erythropoietin; parenteral

4.7

52.5

123

267

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

52.4

334

1356

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

52.3

6615

58205

L04AX01

ATC

azathioprine; systemic

2.2

52.3

438

2005

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

52.3

599

3090

1518, ,

Kela drug reimbursment

13.8

51.9

A07AA02

ATC

nystatin; oral

2.0

51.8

579

2960

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.2

51.4

136

325

TK800

NOMESCO Finland

Hemodialysis

2.9

51.4

239

825

N05BA04

ATC

oxazepam; oral

1.5

51.3

2323

17143

C07AB07

ATC

bisoprolol; oral

1.4

51.3

4411

36405

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

51.1

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

4.3

51.0

131

306

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

17.9

50.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

50.0

221

741

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

49.9

2611

19778

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.2

49.7

134

325

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

49.1

867

5130

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

10.4

49.0

R06AE07

ATC

cetirizine; oral

1.4

49.0

3959

32268

D76.3

ICD-10 Finland

Other histiocytosis syndromes

+∞

49.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

48.9

219

740

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

48.8

454

2168

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

20.6

48.7

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

16.5

48.7

P01AB01

ATC

metronidazole; oral, rectal

1.4

48.6

3570

28640

B72

ICPC

Hodgkin Lymphoma

15.6

48.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

48.4

564

2925

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.4

48.3

179

540

SPAT1088

SPAT

Blood transfusion

5.7

48.2

160

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.9

48.1

229

801

J05AB01

ATC

aciclovir; systemic

1.5

48.1

1941

13984

28900

ICD-8 Finland

Other disease of blood and blood-forming organs, Polycythaemia, secondary

+∞

47.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

47.9

480

2357

ZZF00

NOMESCO Finland

Graft of adipose tissue

4.5

47.9

117

263

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.6

47.8

290

1150

R18

ICD-10 Finland

Ascites

2.9

47.2

221

766

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

17.0

47.1

L01EL01

ATC

ibrutinib; oral

16.1

46.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

46.7

955

5881

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.5

46.5

113

253

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

46.4

141

373

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.1

46.1

194

633

TGD00

NOMESCO Finland

Needle biopsy of lung

6.0

46.1

136

6BA02, ,

NOMESCO Finland

7.4

45.7

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

6.5

45.4

115

B01AB04

ATC

dalteparin; parenteral

2.0

45.4

505

2577

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

45.1

479

2404

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.6

45.1

263

1023

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

44.9

304

1269

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

44.9

1159

7566

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

44.6

368

1674

Z51.0

ICD-10 Finland

Radiotherapy session

3.5

44.3

155

451

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

44.3

351

1570

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

44.2

426

2061

L02BG03

ATC

anastrozole; oral

3.1

44.2

191

633

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

43.7

1633

11560

L01XE33

ATC

[U] palbociclib

6.5

43.3

108

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

7.7

43.3

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.1

43.1

182

595

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

42.9

1643

11681

A02BC01

ATC

omeprazole; systemic

1.4

42.9

2432

18597

C50

ICD-10 Finland

Malignant neoplasm of breast

2.6

42.8

259

1026

C03DA01

ATC

spironolactone; oral

1.6

42.7

1048

6753

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

42.3

566

3074

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

42.3

1436

9958

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

7.1

42.3

N06AX16

ATC

venlafaxine; oral

1.6

42.2

1207

8060

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

3.2

42.0

170

542

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

7.6

41.9

SPAT1254

SPAT

Administration of medicine

1.5

41.9

1293

8784

A06AH03

ATC

naloxegol; oral

3.2

41.8

163

508

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

41.8

461

2344

JAH00

NOMESCO Finland

Laparotomy

2.4

41.4

278

1156

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.7

41.4

224

839

R71

ICD-10 Finland

Abnormality of red blood cells

7.9

41.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.9

41.2

194

675

J01CA04

ATC

amoxicillin; systemic

1.4

41.0

7652

70014

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

40.8

330

1489

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.6

40.8

234

903

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

5.0

40.5

176

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.9

40.2

118

305

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

5.1

40.1

166

RS220, ,

NOMESCO Finland

3.3

39.9

152

467

A02BC05

ATC

esomeprazole; systemic

1.3

39.8

3659

30126

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.0

39.8

113

285

SPAT1262

SPAT

Handing over of treatment supplies

1.5

39.8

1561

11136

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

39.5

172

573

WX002

NOMESCO Finland

Sedation and analgesia

1.4

39.4

1731

12617

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

3.0

39.2

170

565

A10AB05

ATC

insulin aspart; parenteral

1.8

39.1

677

3976

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.3

38.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

38.6

1306

9036

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

4.6

38.6

195

28998

ICD-8 Finland

Other disease of blood and blood-forming organs, Alii definiti

+∞

38.6

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

7.2

38.5

A03

ICPC

Fever

1.5

38.3

1405

9886

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

38.1

689

4095

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

38.0

989

6453

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.7

38.0

203

756

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

5.6

37.9

127

N28.0

ICD-10 Finland

Ischaemia and infarction of kidney

8.6

37.8

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.8

37.8

190

685

S97

ICPC

Chronic ulcer skin

1.8

37.8

540

2994

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

4.0

37.6

108

275

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.5

37.4

234

942

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

37.3

153

492

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

37.1

367

1793

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

2.9

37.1

173

599

A28

ICPC

Limited function/disability NOS

1.5

37.0

1436

10208

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

9.0

36.8

SPAT1263

SPAT

Sampling

1.3

36.8

3686

30628

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

36.6

541

3031

R03BB04

ATC

tiotropium bromide; inhalant

1.6

36.5

874

5588

R03AC02

ATC

salbutamol; inhalant

1.3

36.4

4883

42205

C83.00

ICD-10 Finland

Lymphocytic lymphoma

7.0

36.4

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.8

36.1

188

691

WW402

NOMESCO Finland

Leucoferesis

11.6

36.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

36.0

3661

30455

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

35.9

198

749

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

35.8

566

3236

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

35.7

719

4399

WNF00

NOMESCO Finland

Infection source and contact determination

5.8

35.6

110

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.0

35.3

104

L01AA01

ATC

cyclophosphamide; systemic

5.8

35.3

111

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

35.1

565

3247

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

35.0

1149

7890

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

34.8

1994

15193

1XC03, ,

NOMESCO Finland

5.8

34.8

109

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

13.2

34.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

34.7

555

3183

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.4

34.5

201

28999

ICD-8 Finland

Other disease of blood and blood-forming organs, Other and unspecified

+∞

34.4

D76.00

ICD-10 Finland

Eosinophilic granuloma

+∞

34.4

5BA08, ,

NOMESCO Finland

4.9

34.3

154

TAB00

NOMESCO Finland

Lumbar puncture

2.0

34.2

401

2084

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

34.0

208

829

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

3.5

33.9

118

343

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.6

33.9

111

310

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

33.9

185

697

N02AA01

ATC

morphine; systemic, rectal

2.8

33.9

168

602

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

33.8

291

1348

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

33.7

621

3710

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

33.6

514

2909

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

33.5

400

2092

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

33.2

3339

27648

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

33.2

4063

34541

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

33.1

3683

30909

L01EF01

ATC

palbociclib; oral

5.9

33.0

101

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

32.9

165

595

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

32.8

349

1752

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

3.3

32.8

123

375

D64.8

ICD-10 Finland

Other specified anaemias

2.7

32.8

178

669

ZX131

NOMESCO Finland

Intrathecal

44.6

32.7

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

2.9

32.5

153

533

3AA02, ,

NOMESCO Finland

48.9

32.5

N06AX11

ATC

mirtazapine; oral

1.3

32.4

2901

23619

B01AA03

ATC

warfarin; systemic

1.4

32.4

1566

11575

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

32.3

245

1077

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

13.0

32.3

L28

ICPC

Limited function/disability (L)

1.4

32.0

1486

10900

WF002

NOMESCO Finland

Radical radiotherapy

1.8

32.0

488

2758

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1.9

31.9

392

2070

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

31.7

231

997

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.4

31.7

112

329

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.6

31.6

161

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

31.6

122

379

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.8

31.4

251

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

31.4

463

2591

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

31.4

589

3534

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

4.9

31.3

143

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

31.2

410

2212

HAE99

NOMESCO Finland

Other reconstruction of breast

3.8

31.2

248

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.5

31.0

106

305

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

30.9

724

4599

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

30.8

595

3597

ZXA00

NOMESCO Finland

Right side

1.3

30.8

2267

17920

J02AC01

ATC

fluconazole; systemic

1.3

30.7

3301

27504

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.7

30.7

169

640

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.8

30.5

150

535

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

3.2

30.5

121

382

N05AH04

ATC

quetiapine; oral

1.4

30.2

1415

10387

D71

ICD-10 Finland

Functional disorders of polymorphonuclear neutrophils

+∞

30.2

2880B

ICD-9 Finland

Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, E MEDICAMENTIS]

+∞

30.2

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

5.4

30.1

110

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.1

29.9

127

418

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

12.0

29.9

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

8.0

29.8

S18

ICPC

Laceration/cut

1.3

29.7

4031

34561

L04AX03

ATC

methotrexate; systemic

1.6

29.7

819

5407

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

29.6

207

878

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

29.6

553

3314

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.8

29.5

146

523

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

5.1

29.4

120

B02.9

ICD-10 Finland

Zoster without complication

1.7

29.3

570

3453

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.7

29.3

250

D72.0

ICD-10 Finland

Genetic anomalies of leukocytes

+∞

29.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

29.0

253

1178

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

29.0

248

1146

N05AD01

ATC

haloperidol; systemic

2.1

28.9

262

1239

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

4.6

28.8

145

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

28.7

353

1864

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

28.5

1249

9053

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

28.5

381

2068

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

28.5

301

1508

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.3

28.5

109

337

R50.8

ICD-10 Finland

Other specified fever

4.0

28.3

206

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

28.3

773

5090

P01BA02

ATC

hydroxychloroquine; oral

1.6

28.2

704

4538

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

28.2

1465

10938

ZX114

NOMESCO Finland

Intramuscular

2.8

28.2

143

519

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

28.2

205

885

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.5

28.1

276

PJW99

NOMESCO Finland

Other operation on lymphatic system

4.6

27.9

145

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

5.3

27.9

107

K92.1

ICD-10 Finland

Melaena

1.8

27.8

451

2597

N04AA02

ATC

biperiden; systemic

2.5

27.7

174

703

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

27.7

3870

33206

3AC01, ,

NOMESCO Finland

3.3

27.7

105

323

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.0

27.6

201

ZXA05

NOMESCO Finland

Left side

1.3

27.6

2081

16468

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

5.6

27.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

27.5

1342

9913

A07EA06

ATC

budesonide; oral, local oral

2.0

27.5

309

1583

N05AA02

ATC

levomepromazine; systemic

1.9

27.4

331

1737

L04AA01

ATC

[U] ciclosporin

2.8

27.4

141

516

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

4.9

27.4

120

WPA13

NOMESCO Finland

Palliative consultation

5.6

27.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.1

27.3

111

356

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.9

27.2

199

XX9CD

NOMESCO Finland

Very extensive complementary CT

10.4

27.1

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.1

27.0

110

H02AB04

ATC

methylprednisolone; systemic

1.4

27.0

1208

8783

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

27.0

215

965

3030

Kela drug reimbursment

Abemaciclib

8.4

27.0

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.6

26.9

246

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

3.3

26.9

100

304

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

26.7

346

1860

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.4

26.5

178

742

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.2

26.5

106

337

1515, ,

Kela drug reimbursment

8.2

26.5

N05CD07

ATC

temazepam; oral

1.5

26.4

941

6551

JAH01

NOMESCO Finland

Laparoscopy

1.9

26.4

366

2010

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.4

26.3

152

WVA20

NOMESCO Finland

Medicine administration

2.2

26.3

229

1067

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.9

26.3

123

428

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

26.2

237

1121

N05BA01

ATC

diazepam; systemic, rectal

1.4

26.2

1060

7567

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

25.8

26.1

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

3.8

26.1

205

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

26.1

755

5034

D76.01

ICD-10 Finland

Histiocytosis X (chronic)

+∞

26.0

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.4

26.0

185

791

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

26.0

1075

7700

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

9.7

25.9

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

25.8

1571

12021

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.9

25.8

120

416

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.4

25.8

282

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

25.7

1120

8099

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

27.0

25.7

D73.3

ICD-10 Finland

Abscess of spleen

261.3

25.7

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.5

25.7

162

656

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.6

25.7

148

574

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

25.4

801

5437

E87.6

ICD-10 Finland

Hypokalaemia

2.0

25.4

290

1493

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.2

25.4

310

J01AA02

ATC

doxycycline; systemic

1.3

25.3

7072

65440

M05BA04

ATC

alendronic acid; oral

1.6

25.2

690

4544

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.3

25.1

282

L01XE18

ATC

[U] ruxolitinib

30.1

24.9

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

24.8

245

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.8

24.8

199

L02AE03

ATC

goserelin; implant

2.9

24.8

116

404

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.9

24.8

116

404

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

24.7

197

885

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

24.7

425

2490

1CX01, ,

NOMESCO Finland

7.5

24.6

L01EF03

ATC

abemaciclib; oral

7.5

24.6

Z94.2

ICD-10 Finland

Lung transplant status

6.8

24.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

24.6

542

3391

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

24.5

1660

12901

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.7

24.5

205

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.4

24.5

252

GEA00

NOMESCO Finland

Mediastinoscopy

4.8

24.5

116

B28

ICPC

Limited function/disability (B)

4.1

24.5

161

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.3

24.4

192

858

A10AE04

ATC

insulin glargine; parenteral

1.5

24.3

773

5258

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

24.2

319

1724

R60.0

ICD-10 Finland

Localized oedema

1.4

24.2

1018

7313

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

24.2

213

997

L03AA04, ,

ATC

7.6

24.2

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.3

24.2

274

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

24.2

284

1478

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.0

24.1

167

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.9

24.0

113

395

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

5.1

23.9

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

23.8

111

386

N05AF05

ATC

zuclopenthixol; systemic

3.2

23.8

297

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

4.6

23.7

123

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

23.7

1550

11978

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

23.6

207

968

N05AX12

ATC

aripiprazole; systemic

1.9

23.5

295

1569

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.6

23.5

132

506

ZX100

NOMESCO Finland

Oral

2.6

23.5

137

535

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.1

23.5

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

23.4

594

3845

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

4.6

23.3

121

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

23.2

234

1153

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.2

23.2

187

845

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

3.4

23.1

247

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.0

23.0

103

350

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.6

23.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

22.9

730

4966

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.5

22.8

141

566

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

22.7

455

2779

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

8.1

22.6

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.1

22.6

149

122

Kela drug reimbursment

Aplastic anaemia

18.9

22.5

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

22.5

637

4224

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.6

22.5

208

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

22.4

404

2397

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

22.4

666

4463

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.1

22.3

146

D07AC01

ATC

betamethasone; topical

1.3

22.3

3026

25697

B04

ICPC

Blood symptom/complaint

3.8

22.2

182

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

5.5

22.2

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

21.4

22.1

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.7

22.0

188

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

21.8

118

444

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

21.8

3254

27914

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

6.3

21.8

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

21.7

146

610

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

21.6

3292

28300

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

5.5

21.4

WX882

NOMESCO Finland

High dependency care

2.0

21.4

247

1278

N05AL05

ATC

amisulpride; oral

8.3

21.4

-50

ICPC

Medication/prescr/renewal

1.8

21.4

337

1926

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

21.4

613

4077

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

21.2

174

792

XX1AD

NOMESCO Finland

Other CT-examination

3.3

21.2

236

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

21.2

483

3047

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

21.0

453

2817

N03AG01

ATC

valproic acid; systemic, rectal

1.6

21.0

463

2895

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

6.3

21.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

20.9

2479

20694

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

20.9

119

460

J02AC04

ATC

posaconazole; systemic

17.8

20.8

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.1

20.7

185

872

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

4.5

20.5

109

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

5.1

20.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

5.1

20.5

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

20.4

669

4575

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.9

20.4

336

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.2

20.4

247

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

20.3

538

3515

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

20.3

300

1683

Z94.4

ICD-10 Finland

Liver transplant status

4.4

20.0

111

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

20.0

184

877

L01BC59

ATC

trifluridine, combinations; systemic

4.8

19.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

19.8

316

1812

RS221, ,

NOMESCO Finland

2.5

19.8

128

526

N05CF02

ATC

zolpidem; oral

1.3

19.8

1375

10702

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

5.7

19.7

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.2

19.7

232

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

19.7

317

1823

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

19.6

183

878

A11CC03

ATC

alfacalcidol; systemic

2.0

19.6

197

972

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

19.5

135

572

WZC15, ,

NOMESCO Finland

3.5

19.4

185

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

3.3

19.4

214

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

19.4

2335

19494

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.4

19.4

A10AC01

ATC

insulin (human); parenteral

1.5

19.4

556

3698

B37.08

ICD-10 Finland

Other candidal stomatitis

3.0

19.3

292

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.6

19.3

106

403

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

19.3

170

798

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.4

19.1

128

535

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

19.1

1040

7798

J32.4

ICD-10 Finland

Chronic pansinusitis

2.4

19.0

129

542

I50.0

ICD-10 Finland

Congestive heart failure

1.5

19.0

524

3455

JFB00

NOMESCO Finland

Partial resection of small intestine

2.4

19.0

134

573

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

19.0

122

500

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

19.0

247

1332

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

18.9

594

4025

E000001, ,

ATC

1.3

18.9

1556

12389

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

18.9

110

430

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

18.9

110

430

L01BB02

ATC

mercaptopurine; oral

2.7

18.9

356

KFC00

NOMESCO Finland

Unilateral orchiectomy

3.5

18.9

184

R4120

NOMESCO Finland

Occupational therapy

1.5

18.9

515

3388

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

18.8

234

1243

B29

ICPC

Lymph/immune mech sympt/complt other

4.1

18.8

121

ZY000

NOMESCO Finland

Hospital inpatient

2.6

18.7

105

403

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

1.8

18.7

266

1474

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

18.7

428

2702

XX7BT

NOMESCO Finland

Radioactive phosphorus therapy

27.8

18.7

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

18.7

442

2814

J96.1

ICD-10 Finland

Chronic respiratory failure

2.1

18.6

168

796

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

18.6

490

3199

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

1.8

18.6

276

1551

D75

ICD-10 Finland

Other diseases of blood and blood-forming organs

100.2

18.5

Z94.1

ICD-10 Finland

Heart transplant status

6.1

18.5

B01AC14

ATC

[U] anagrelide

190.3

18.5

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.3

18.5

211

UKC02

NOMESCO Finland

Cystoscopy

1.3

18.4

1270

9863

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

18.3

530

3530

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

18.3

270

1514

JAL30

NOMESCO Finland

Omentectomy

2.5

18.3

111

443

L01BA01

ATC

methotrexate; systemic

1.8

18.3

296

1706

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.6

18.2

103

397

R51.80

ICD-10 Finland

Headache

1.3

18.2

1181

9090

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

18.2

791

5707

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

4.1

18.1

120

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

18.1

346

2087

R02

ICPC

Shortness of breath/dyspnoea

1.4

18.1

1020

7686

N03AX14

ATC

levetiracetam; systemic

1.9

18.1

228

1217

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.9

18.0

293

J12.8

ICD-10 Finland

Other viral pneumonia

2.8

18.0

315

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

18.0

363

2222

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

3.2

17.9

215

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

3.5

17.9

171

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.2

17.9

155

722

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

17.9

526

3516

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

17.9

887

6545

ZXA10

NOMESCO Finland

Bilateral

1.3

17.9

1480

11787

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

5.5

17.9

H03AA01

ATC

levothyroxine sodium; systemic

1.3

17.9

1863

15276

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

17.8

311

1830

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

17.8

346

2096

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

17.8

991

7450

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

17.8

356

JJC00

NOMESCO Finland

Allogenic transplantation of liver

4.9

17.8

2883X

ICD-9 Finland

Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]

+∞

17.7

2888A

ICD-9 Finland

Diseases of white blood cells, Other specified disease of white blood cells[LEUCOCYTOSIS]

+∞

17.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

17.6

345

2094

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

3.5

17.6

173

V03AE01

ATC

polystyrene sulfonate; oral

2.5

17.6

110

445

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

6.1

17.6

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

5.0

17.6

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

3.2

17.6

223

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

17.5

2370

20011

1BC07, ,

NOMESCO Finland

180.3

17.5

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

17.5

565

3853

163

Kela drug reimbursment

Abiraterone and enzalutamide

2.8

17.5

309

HAB99

NOMESCO Finland

Other partial excision of mammary gland

2.0

17.4

196

1007

SPAT1260

SPAT

Consultation of another employee

1.3

17.4

1408

11175

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.8

17.4

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.8

17.4

237

1298

GDG10

NOMESCO Finland

Bilateral transplantation of lung

7.0

17.4

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

16.9

17.3

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

18.6

17.3

XX2RW, ,

NOMESCO Finland

2.6

17.3

373

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

17.3

223

1200

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

20.9

17.3

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

17.2

1086

13974

JAL00

NOMESCO Finland

Biopsy of peritoneum

3.4

17.2

181

SPAT1301

SPAT

No procedures

1.2

17.1

2559

21830

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.4

17.1

120

512

J01DA01

ATC

[U] cefalexin

1.2

17.1

5336

48829

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.1

17.1

152

716

I81

ICD-10 Finland

Portal vein thrombosis

3.9

17.1

130

ZX110

NOMESCO Finland

Intracutaneous

5.8

17.1

N17.8

ICD-10 Finland

Other acute renal failure

2.5

17.1

107

434

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

4.3

17.0

100

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

3.1

17.0

217

TJA10

NOMESCO Finland

Laparocentesis

4.5

17.0

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.0

17.0

254

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

17.0

191

982

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

17.0

554

3786

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

7.2

16.9

R04.0

ICD-10 Finland

Epistaxis

1.5

16.9

581

4010

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

16.9

584

4035

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.6

16.9

154

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

16.9

1893

15641

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

16.9

805

5901

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.3

16.9

193

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.5

16.9

159

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.7

16.9

145

T90

ICPC

Diabetes non-insulin dependent

1.3

16.8

1918

15879

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.8

16.8

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.3

16.7

184

A12AA04

ATC

calcium carbonate; oral

2.3

16.7

125

549

A02BC03

ATC

lansoprazole; oral

1.2

16.6

2327

19706

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

15.0

16.6

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

16.6

249

1404

M10.9

ICD-10 Finland

Gout, unspecified

1.5

16.6

520

3524

A01AB09

ATC

miconazole; local oral

1.4

16.6

658

4669

N05AF03

ATC

chlorprothixene; systemic

1.9

16.6

196

1025

N05AN01

ATC

lithium; oral

2.0

16.5

177

894

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.4

16.5

110

459

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

16.5

217

1175

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.3

16.5

124

546

WW400

NOMESCO Finland

Plasmaferesis

5.9

16.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

16.5

2071

17331

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

16.4

523

3556

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

16.3

162

796

WX872

NOMESCO Finland

Intensive care

1.6

16.3

393

2513

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

3.8

16.3

130

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

3.3

16.2

178

JFF10

NOMESCO Finland

Loop enterostomy

3.3

16.2

178

K12.18

ICD-10 Finland

Other forms of stomatitis

3.0

16.2

245

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

16.2

539

3699

N03AX12

ATC

[U] gabapentin; oral

1.3

16.1

1288

10198

Z2445

NOMESCO Finland

Psychologist

1.7

16.1

285

1685

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

3.4

16.1

164

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

16.0

636

4512

N05AX08

ATC

risperidone; systemic

1.5

16.0

586

4096

I50.1

ICD-10 Finland

Left ventricular failure

1.6

16.0

346

2157

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.7

16.0

132

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.5

16.0

102

418

WX610

NOMESCO Finland

Patient controlled analgesia

3.2

15.9

200

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

15.9

835

6217

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

4.9

15.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

15.9

203

1090

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

15.8

1641

13425

9101

FHL

Bone biopsy

5.7

15.8

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

15.8

156

766

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

15.8

315

1924

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

15.7

255

1471

D61.0

ICD-10 Finland

Constitutional aplastic anaemia

33.4

15.7

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

5.8

15.7

D73.2

ICD-10 Finland

Chronic congestive splenomegaly

+∞

15.6

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

4.5

15.6

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

3.9

15.6

116

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

15.6

2129

17963

SAA04

NOMESCO Finland

Special examination of mouth

1.6

15.6

403

2621

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

15.5

735

5380

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

15.5

890

6719

A07EC02

ATC

mesalazine; oral, rectal

1.6

15.5

391

2527

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

15.5

2486

21326

D07AB08

ATC

desonide; topical

1.4

15.5

819

6105

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

15.5

337

2104

J01FA06

ATC

roxithromycin; oral

1.2

15.5

3258

28686

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

15.5

1908

15920

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

3.6

15.4

140

1CD01, ,

NOMESCO Finland

4.8

15.4

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

38.1

15.4

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.7

15.4

131

XX1XN

NOMESCO Finland

Other isotope examination

2.8

15.3

269

SPAT1153

SPAT

Removal of sutures

1.2

15.3

2611

22530

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

1.9

15.3

200

1082

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

15.3

538

3733

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

15.2

149

729

M05.0

ICD-10 Finland

Felty syndrome

7.0

15.2

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.9

15.2

204

1112

E87.5

ICD-10 Finland

Hyperkalaemia

2.1

15.2

139

663

WX730

NOMESCO Finland

Conventional respirator

2.2

15.2

123

559

150

Kela drug reimbursment

Dasatinib

28.6

15.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

4.6

15.1

A29

ICPC

General symptom/complaint other

1.3

15.1

972

7464

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

4.1

15.1

101

N05AB03

ATC

perphenazine; systemic, rectal

1.7

15.1

260

1527

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

1.9

15.1

181

952

N30.0

ICD-10 Finland

Acute cystitis

1.3

15.1

1231

9771

152

Kela drug reimbursment

Nilotinib

20.0

15.1

D58.2

ICD-10 Finland

Other haemoglobinopathies

11.8

15.0

153

Kela drug reimbursment

Lenalidomid

3.2

15.0

187

C20

ICD-10 Finland

Malignant neoplasm of rectum

2.8

15.0

256

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

15.0

208

1147

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

14.9

1527

12465

D07AA02

ATC

hydrocortisone; topical

1.3

14.9

1039

8072

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.5

14.8

360

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.1

14.8

133

630

F20.10

ICD-10 Finland

Raise schizophrenia continuously

3.7

14.8

125

C09AA05

ATC

ramipril; oral

1.2

14.8

1966

16525

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

14.8

425

2829

C83.71

ICD-10 Finland

Burkitt's tumour

31.7

14.8

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.0

14.7

161

820

5AB14, ,

NOMESCO Finland

5.5

14.7

UDC00

NOMESCO Finland

Ear microscopy

1.4

14.7

574

4059

9945/3-C42.1

ICD-O-3

Chronic myelomonocytic leukemia, NOS, of bone marrow

16.5

14.7

D69.4

ICD-10 Finland

Other primary thrombocytopenia

11.3

14.7

Y28

ICPC

Limited function/disability (Y)

3.9

14.7

112

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

4.7

14.7

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.1

14.6

200

R84

ICPC

Malignant neoplasm bronchus/lung

3.7

14.6

126

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.8

14.6

117

L02BB04

ATC

enzalutamide; oral

2.7

14.6

293

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.7

14.6

299

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

14.6

1435

11657

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

14.6

282

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.0

14.6

156

789

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

3.3

14.6

165

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

14.6

193

1049

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

3.6

14.5

127

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

14.5

208

1159

9109

FHL

Other measure in this category

5.4

14.4

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

2.9

14.4

223

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

14.3

140

685

R05

ICD-10 Finland

Cough

1.2

14.3

1703

14138

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

14.3

1072

8408

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

3.2

14.3

177

RD210, ,

NOMESCO Finland

2.0

14.3

145

720

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

1.9

14.3

163

844

Z85.6

ICD-10 Finland

Personal history of leukaemia

27.2

14.2

L95.8

ICD-10 Finland

Other vasculitis limited to skin

4.4

14.2

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

19.1

14.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

4.6

14.2

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

6.2

14.2

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

10.4

14.2

E86

ICD-10 Finland

Volume depletion

1.9

14.2

175

930

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

2.6

14.2

298

J01FA10

ATC

azithromycin; systemic

1.2

14.1

4825

44181

XX9XW, ,

NOMESCO Finland

2.9

14.1

226

9983/3-C42.1

ICD-O-3

Myelodysplastic syndrome with excess blasts of bone marrow

42.5

14.1

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

14.1

687

5054

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

3.6

14.1

125

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.1

14.1

138

677

1AA09, ,

NOMESCO Finland

11.9

14.0

C01AA05

ATC

digoxin; systemic

1.4

14.0

530

3727

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

14.0

161

835

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

14.0

515

3603

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

10.9

14.0

L04AX04

ATC

lenalidomide; oral

3.1

13.9

185

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

13.9

272

1653

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

2.7

13.9

272

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

13.9

165

866

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

6.0

13.8

P72

ICPC

Schizophrenia

2.0

13.8

139

688

J01XX08

ATC

linezolid; systemic

3.0

13.8

202

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.3

13.8

151

SPAT1104

SPAT

Monitoring of emergency patient

1.5

13.8

495

3449

L01XX28

ATC

[U] imatinib

20.0

13.7

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.0

13.7

192

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.0

13.7

192

D68.8

ICD-10 Finland

Other specified coagulation defects

2.4

13.7

374

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

6.2

13.7

B82

ICPC

Anaemia other/unspecified

1.8

13.7

206

1164

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.2

13.7

117

544

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

10.4

13.7

3028

Kela drug reimbursment

Mepolizumab

10.4

13.7

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.9

13.7

179

970

HAD99

NOMESCO Finland

Other plastic operation on breast

3.0

13.6

198

N06AB04

ATC

citalopram; systemic

1.2

13.6

1608

13331

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.1

13.6

129

625

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

13.6

388

2580

N03AX09

ATC

lamotrigine; oral

1.6

13.6

326

2085

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

3.7

13.6

114

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

2.8

13.6

231

D708, ,

ICD-10 Finland

+∞

13.5

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

4.8

13.5

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

5.9

13.5

E83.50

ICD-10 Finland

Hypercalcemia

2.2

13.5

109

496

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.3

13.5

433

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.6

13.4

306

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.4

13.4

384

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

2.8

13.4

238

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

3.8

13.4

106

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

13.4

397

2662

OAB43, ,

SPAT

0.8

13.3

1304

15922

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

3.0

13.3

190

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

13.3

2106

17997

R03BA05

ATC

fluticasone; inhalant

1.3

13.3

1396

11418

B84

ICPC

Unexplained abnormal white cells

21.1

13.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

13.3

1031

8122

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.6

13.3

296

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.3

13.2

101

449

AAA10

NOMESCO Finland

Biopsy through craniotomy

10.4

13.2

297, ,

Kela drug reimbursment

10.4

13.2

R03DX09

ATC

mepolizumab; parenteral

9.7

13.2

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.2

13.2

111

514

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.4

13.2

351

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

2.9

13.2

213

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

13.1

629

4613

A04AA03

ATC

tropisetron; systemic

4.2

13.1

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

13.1

386

2584

ZXY60

NOMESCO Finland

2-person team, nurses

3.3

13.1

141

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

15.0

13.1

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

5.9

13.0

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.2

13.0

112

523

D69.0

ICD-10 Finland

Allergic purpura

2.8

13.0

220

1XX32, ,

NOMESCO Finland

10.9

13.0

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

3.1

13.0

167

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.8

13.0

189

1059

J05AX18

ATC

letermovir; oral

28.4

12.9

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

12.9

317

2038

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

2.5

12.9

318

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

12.9

394

2657

A04

ICPC

Weakness/tiredness general

1.3

12.9

1082

8614

Z71.8

ICD-10 Finland

Other specified counselling

1.2

12.8

2423

21045

C08CA05

ATC

nifedipine; systemic

1.5

12.8

441

3046

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

12.8

168

911

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.8

12.8

192

1085

K83.0

ICD-10 Finland

Cholangitis

2.1

12.8

113

533

TGA30

NOMESCO Finland

Thoracocentesis

2.8

12.8

222

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.9

12.8

168

912

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

12.8

423

2901

SPAT1240

SPAT

Therapeutic discussion

1.4

12.7

716

5387

E000006, ,

ATC

1.4

12.7

502

3559

R31

ICD-10 Finland

Unspecified haematuria

1.3

12.7

753

5710

K92.0

ICD-10 Finland

Haematemesis

1.8

12.7

174

957

R04.2

ICD-10 Finland

Haemoptysis

1.6

12.7

255

1563

K83.1

ICD-10 Finland

Obstruction of bile duct

2.1

12.6

110

516

N18.0

ICD-10 Finland

End-stage renal disease

2.4

12.6

352

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.3

12.6

383

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

12.6

634

4688

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

15.4

12.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

12.6

886

6888

S36.0

ICD-10 Finland

Injury of spleen

4.5

12.6

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

4.5

12.6

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

12.6

173

953

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.2

12.6

440

R05

ICPC

Cough

1.2

12.5

1871

15886

SPAT1229

SPAT

Assessment of need for aid

1.4

12.5

570

4144

K86.3

ICD-10 Finland

Pseudocyst of pancreas

3.3

12.5

145

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.0

12.5

134

679

2890X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Polycythaemia, secondary[ERYTHROCYTOSIS SECUNDARIA, NUD]

+∞

12.5

2898X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs

+∞

12.5

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.6

12.5

276

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

12.5

551

3985

P99

ICPC

Psychological disorders other

1.8

12.5

196

1123

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

11.0

12.5

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

4.1

12.5

SPAT1211

SPAT

Application of soft bandage

1.4

12.5

653

4860

A91

ICPC

Abnormal result investigation NOS

1.5

12.4

357

2377

OAA67, ,

SPAT

0.7

12.4

549

7479

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

24.3

12.4

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

12.4

1933

16477

B02BX05

ATC

eltrombopag; oral

9.3

12.4

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

3.7

12.4

107

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.1

12.4

161

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

20.0

12.4

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

12.4

648

4819

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

2.7

12.4

243

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.4

12.3

332

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

11.6

12.3

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.2

12.3

438

L02BX03

ATC

abiraterone; oral

2.8

12.3

216

D46.1

ICD-10 Finland

Refractory anaemia with ring sideroblasts

14.3

12.2

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

12.2

194

1115

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.3

12.2

382

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.1

12.2

106

497

E89.4

ICD-10 Finland

Postprocedural ovarian failure

10.5

12.2

C95.9

ICD-10 Finland

Leukaemia, unspecified

9.6

12.2

V03AF03

ATC

calcium folinate; systemic

5.1

12.2

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

3.1

12.2

158

X21

ICPC

Breast sympt/compl female other

1.9

12.2

145

763

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

12.2

647

4827

SCA02

NOMESCO Finland

Preventive oral health care

1.3

12.1

741

5648

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

3.9

12.0

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.5

12.0

299

SPAT1281

SPAT

Other administrative function

1.4

12.0

571

4182

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.4

12.0

124

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

11.0

12.0

V03AC03

ATC

deferasirox; oral

21.3

12.0

N06AB10

ATC

escitalopram; oral

1.2

12.0

1487

12384

JN5AN

NOMESCO Finland

Total body isotope imaging

10.0

12.0

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

3.1

11.9

160

K65.0

ICD-10 Finland

Acute peritonitis

2.3

11.9

380

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

11.9

571

4189

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

11.9

2090

18017

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

4.4

11.9

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

11.9

581

4277

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

4.5

11.9

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

3.3

11.9

130

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

3.6

11.8

106

N03AE01

ATC

clonazepam; systemic

1.5

11.8

419

2913

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

11.8

346

2315

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.2

11.8

100

465

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.7

11.8

238

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.8

3520

31737

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

4.1

11.8

E29.1

ICD-10 Finland

Testicular hypofunction

2.3

11.8

395

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

11.7

932

7362

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

11.7

346

2318

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

5.1

11.7

B59

ICD-10 Finland

Pneumocystosis

8.9

11.7

D69.1

ICD-10 Finland

Qualitative platelet defects

8.9

11.7

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.5

11.7

307

2006

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

11.7

1428

11871

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

2.6

11.6

245

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.7

11.6

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

3.0

11.6

168

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

11.6

845

6600

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

18.9

11.6

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

2.3

11.6

354

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.6

11.6

246

IEY01

NOMESCO Finland

Psychoeducation, individual

2.9

11.5

190

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

2.9

11.5

190

329

Kela drug reimbursment

Lenalidomide

3.1

11.5

148

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.8

11.5

161

893

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.9

11.5

147

793

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.3

11.4

128

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.9

11.4

143

765

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

2.8

11.4

191

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

13.6

11.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.3

11.4

381

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

3.5

11.4

109

C07AB02

ATC

metoprolol; systemic

1.2

11.4

1502

12587

R33

ICD-10 Finland

Retention of urine

1.4

11.4

555

4085

K76.9

ICD-10 Finland

Liver disease, unspecified

2.1

11.3

109

532

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

11.3

1689

14324

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.5

11.3

339

2279

V03AE02

ATC

sevelamer; oral

3.0

11.3

165

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

11.3

352

2385

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.8

11.3

161

897

K50.8

ICD-10 Finland

Other Crohn disease

2.1

11.3

108

526

R52.9

ICD-10 Finland

Pain, unspecified

1.3

11.3

719

5510

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.0

11.3

110

540

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.0

11.3

115

574

V03AG01

ATC

sodium cellulose phosphate; systemic

8.3

11.3

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

5.1

11.2

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

11.2

267

1706

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

2.6

11.2

238

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

3.1

11.2

145

D46.0

ICD-10 Finland

Refractory anaemia without ring sideroblasts, so stated

9.6

11.2

A99

ICPC

Disease/condition unspecnature/site

1.3

11.2

681

5184

R01AD12

ATC

fluticasone furoate; nasal

1.2

11.2

2389

20935

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

11.2

518

3779

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

3.2

11.2

130

D61.1

ICD-10 Finland

Drug-induced aplastic anaemia

17.0

11.2

C08CA01

ATC

amlodipine; oral

1.2

11.2

3091

27671

R81

ICPC

Pneumonia

1.6

11.2

253

1599

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

4.6

11.2

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.7

11.1

222

328

Kela drug reimbursment

Nilotinib

25.0

11.1

J01FA09

ATC

clarithromycin; systemic

1.2

11.1

2458

21606

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

3.4

11.1

111

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

3.9

11.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.6

11.1

231

1431

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.2

11.1

136

X58

ICD-10 Finland

Exposure to other specified factors

1.3

11.0

1027

8277

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.5

11.0

270

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

3.9

11.0

N05AE04

ATC

ziprasidone; systemic

2.9

11.0

168

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

11.0

342

2319

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

5.0

11.0

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

10.0

11.0

SPAT1290

SPAT

Preparation of deceased person

4.4

11.0

M35.1

ICD-10 Finland

Other overlap syndromes

3.1

10.9

142

N19

ICD-10 Finland

Unspecified kidney failure

1.6

10.9

246

1552

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

2.5

10.9

253

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

2.7

10.9

207

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

2.9

10.9

174

175

Kela drug reimbursment

Deferasirox

43.3

10.9

TQB05

NOMESCO Finland

Puncture of skin of trunk

2.3

10.9

326

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

10.8

818

6418

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.3

10.8

358

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.0

10.8

159

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

2.8

10.7

181

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

10.7

433

3084

A02BA02

ATC

ranitidine; systemic

1.2

10.7

1460

12264

A01

ICPC

Pain general/multiple sites

1.3

10.7

660

5033

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

10.7

650

4947

XQ800

NOMESCO Finland

Prick test

1.4

10.7

508

3721

KAS40

NOMESCO Finland

Excision of transplanted kidney

17.8

10.7

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.3

10.7

360

T81.9

ICD-10 Finland

Unspecified complication of procedure

1.9

10.7

139

754

L01XE06

ATC

[U] dasatinib

21.5

10.7

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

3.7

10.7

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

3.7

10.7

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.3

10.6

317

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

3.0

10.6

155

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.6

10.6

239

D47.0

ICD-10 Finland

Histiocytic and mast cell tumours of uncertain and unknown behaviour

12.9

10.6

9831/3-C42.1

ICD-O-3

T-cell large granular lymphocytic leukemia of bone marrow

60.1

10.6

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.6

10.6

216

A08

ICPC

Swelling

1.5

10.6

361

2493

K12.10

ICD-10 Finland

Stomatitis NOS

2.7

10.6

194

N06AB06

ATC

sertraline; oral

1.3

10.5

781

6115

ZXY49

NOMESCO Finland

Other health care provider

3.3

10.5

120

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

10.5

147

816

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

4.3

10.5

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

10.5

235

1482

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

4.8

10.5

C93.1

ICD-10 Finland

Chronic myelomonocytic leukaemia

14.2

10.5

E000003, ,

ATC

1.5

10.4

298

1985

2387X

ICD-9 Finland

Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]

110.1

10.4

9891/3-C42.1

ICD-O-3

Acute monocytic leukemia of bone marrow

110.1

10.4

D74.9

ICD-10 Finland

Methaemoglobinaemia, unspecified

+∞

10.4

D76.0

ICD-10 Finland

Langerhans' cell histiocytosis, not elsewhere classified

+∞

10.4

D76.2

ICD-10 Finland

Haemophagocytic syndrome, infection-associated

+∞

10.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

10.4

435

3119

B01.9

ICD-10 Finland

Varicella without complication

3.5

10.4

101

R5110, ,

SPAT

1.4

10.4

470

3417

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

10.4

578

4344

GD6AD

NOMESCO Finland

CT of chest and neck

3.2

10.4

126

R03DC03

ATC

montelukast; oral

1.2

10.4

1227

10158

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.8

10.3

163

937

K74.3

ICD-10 Finland

Primary biliary cirrhosis

2.6

10.3

219

372

Kela drug reimbursment

Idelalisib

16.0

10.3

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

16.0

10.3

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

3.6

10.3

C92.5

ICD-10 Finland

Acute myelomonocytic leukaemia

32.5

10.3

RF120, ,

NOMESCO Finland

2.2

10.3

411

WX704

NOMESCO Finland

Intubation

1.3

10.3

582

4383

RF210, ,

NOMESCO Finland

1.7

10.3

198

1202

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

8.2

10.3

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

3.9

10.3

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.8

10.2

145

808

WF099

NOMESCO Finland

Other radiotherapy

2.7

10.2

203

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

2.8

10.2

175

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

3.3

10.2

117

L02AE02

ATC

leuprorelin; implant, parenteral

1.5

10.2

320

2173

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

2.2

10.2

355

ZZA00

NOMESCO Finland

Split skin graft

1.6

10.2

201

1229

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

1.8

10.2

138

759

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.4

10.2

299

J45.8

ICD-10 Finland

Mixed asthma

1.6

10.2

218

1361

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

10.1

138

760

M05BA06

ATC

ibandronic acid; systemic

1.8

10.1

139

768

ICB03, ,

SPAT

3.9

10.1

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

10.1

336

2310

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

2.9

10.1

160

XX4BW, ,

NOMESCO Finland

4.2

10.1

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

10.0

131

712

L01BC53

ATC

tegafur, combinations; systemic

5.0

10.0

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

1.8

10.0

147

828

-44

ICPC

Preventive immunization/medic

1.3

10.0

589

4463

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.1

10.0

423

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

4.8

10.0

QBA00

NOMESCO Finland

Puncture of skin of trunk

3.3

10.0

109

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.9

10.0

125

671

WPB10

NOMESCO Finland

Making a convalescent care decision

3.3

10.0

114

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

9.9

300

2022

NHQ40

NOMESCO Finland

Amputation of toe

2.0

9.9

110

566

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.3

9.9

321

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

3.8

9.9

R55

ICD-10 Finland

Syncope and collapse

1.3

9.9

792

6261

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.4

9.9

284

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

2.4

9.9

278

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

2.7

9.9

184

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

9.9

245

1583

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

9.9

220

1387

J01CF05

ATC

flucloxacillin; systemic

1.4

9.8

429

3099

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.0

9.8

486

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

9.8

348

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.5

9.8

309

2102

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

26.0

9.8

K02.1

ICD-10 Finland

Caries of dentine

1.1

9.8

4861

45256

L01EA03

ATC

nilotinib; oral

20.0

9.8

C92.7

ICD-10 Finland

Other myeloid leukaemia

20.0

9.8

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

20.0

9.8

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

9.8

185

OAA80, ,

SPAT

0.7

9.8

265

3939

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

9.7

380

2692

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

4.0

9.7

B02AA02

ATC

tranexamic acid; systemic

1.2

9.7

1022

8348

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.1

9.7

435

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

1.9

9.7

120

642

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

2.8

9.7

175

RS121, ,

NOMESCO Finland

2.7

9.7

192

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.6

189

1154

N63

ICD-10 Finland

Unspecified lump in breast

1.4

9.6

421

3043

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

2.0

9.6

483

GDC00

NOMESCO Finland

Lobectomy of lung

2.7

9.6

181

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

3.0

9.6

132

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.0

9.6

132

B07.9

ICD-10 Finland

Verruca simplex

1.6

9.6

243

1577

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

9.6

490

3634

UJK02

NOMESCO Finland

ERCP

1.7

9.6

182

1102

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

3.5

9.6

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.6

9.6

190

1164

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

9.6

1333

11219

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.8

9.5

132

731

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.6

9.5

235

1517

SPAT1234

SPAT

Support of social functional capacity

1.4

9.5

348

2437

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

1.9

9.5

112

589

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

9.5

215

1360

B37.8

ICD-10 Finland

Candidiasis of other sites

3.6

9.5

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

15.0

9.5

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

1.7

9.5

160

939

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

9.5

2026

17724

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

9.5

503

3754

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

9.5

279

1873

-60

ICPC

Result test/procedure

1.4

9.4

406

2927

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.2

9.4

113

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

2.4

9.4

266

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.7

9.4

172

-69

ICPC

Other reason for encounter NEC

1.5

9.4

265

1762

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.0

9.4

102

522

N03AX18

ATC

lacosamide; systemic

2.4

9.4

248

324

Kela drug reimbursment

Dasatinib

30.0

9.4

9920/3-C42.1

ICD-O-3

Therapy-related myeloid neoplasm of bone marrow

+∞

9.4

JM1AT

NOMESCO Finland

Cytology of spleen with ultrasound guidance

+∞

9.4

2899X

ICD-9 Finland

Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs

+∞

9.4

2880X

ICD-9 Finland

Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, NUD]

+∞

9.4

E000002, ,

ATC

1.3

9.4

765

6065

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

9.3

652

5063

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.7

9.3

160

943

N06AX21

ATC

duloxetine; oral

1.3

9.3

833

6676

Z52.89

ICD-10 Finland

Donor of other organ or tissue

8.0

9.3

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.8

9.3

139

788

H26.3

ICD-10 Finland

Drug-induced cataract

2.6

9.3

196

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

4.5

9.3

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.8

9.3

137

774

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

4.7

9.3

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

10.6

9.3

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

9.3

260

1728

G04CA02

ATC

tamsulosin; oral

1.2

9.2

1696

14644

Z43.3

ICD-10 Finland

Attention to colostomy

4.0

9.2

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.0

9.2

478

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.7

9.2

180

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.1

9.2

411

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.8

9.2

133

748

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

4.1

9.2

TQW40

NOMESCO Finland

Remowal of suture of skin

1.3

9.2

512

3852

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.1

204

1287

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

3.3

9.1

100

N06DX01

ATC

memantine; oral

0.7

9.1

225

3408

SPAT1310

SPAT

Counselling related to known health issue

1.2

9.1

2468

21997

SPAT1291

SPAT

Other function in accordance with NCSP classification

1.9

9.1

110

585

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

2.9

9.0

137

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.3

9.0

265

E83.1

ICD-10 Finland

Disorders of iron metabolism

2.8

9.0

159

D72

ICD-10 Finland

Other disorders of white blood cells

36.7

9.0

SPAT1325

SPAT

Vaccination

1.2

9.0

2651

23764

L04AA10

ATC

[U] sirolimus

10.0

9.0

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

9.0

227

1474

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.6

9.0

177

1083

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

9.0

343

2422

J47

ICD-10 Finland

Bronchiectasis

1.8

9.0

127

709

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.6

9.0

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

3.0

9.0

127

RS140, ,

NOMESCO Finland

4.1

9.0

ECB20

NOMESCO Finland

Oral alveoplasty

2.1

8.9

362

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.9

203

1287

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

18.6

8.9

2AA01, ,

NOMESCO Finland

24.0

8.9

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

4.2

8.9

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.8

8.9

118

646

UJF02

NOMESCO Finland

Peroral enteroscopy

2.6

8.9

189

J01EA01

ATC

trimethoprim; systemic

1.2

8.9

1945

17042

D61.3

ICD-10 Finland

Idiopathic aplastic anaemia

12.5

8.8

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

12.5

8.8

156

Kela drug reimbursment

Lapatinib

12.5

8.8

L04AA13

ATC

[U] leflunomide

1.6

8.8

176

1080

F20.0

ICD-10 Finland

Paranoid schizophrenia

2.5

8.8

207

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

4.9

8.8

WX740

NOMESCO Finland

Nitrogen oxide therapy

3.6

8.8

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

3.1

8.8

118

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

2.4

8.8

256

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

1.9

8.8

500

B81

ICPC

Anaemia vit B12/folate deficiency

1.5

8.8

267

1805

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.8

8.8

119

656

N02AA03

ATC

hydromorphone; systemic, rectal

3.5

8.8

Z00.8

ICD-10 Finland

Other general examinations

1.3

8.8

539

4113

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

8.8

625

4869

JEA00

NOMESCO Finland

Appendectomy

1.4

8.7

414

3035

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

3.2

8.7

103

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.3

8.7

L95

ICPC

Osteoporosis

1.5

8.7

245

1629

N02BF02

ATC

pregabalin; oral

1.4

8.7

400

2917

K99

ICPC

Cardiovascular disease other

1.6

8.7

184

1146

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

8.7

197

1248

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.0

8.7

433

JFB30

NOMESCO Finland

Right hemicolectomy

1.9

8.7

509

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.4

8.7

233

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

8.7

285

1957

A10AE05

ATC

insulin detemir; parenteral

1.4

8.7

364

2615

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

8.7

219

1423

ZXC40

NOMESCO Finland

Use of ultrasound

2.5

8.7

221

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

8.6

732

5829

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

2.7

8.6

163

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

8.6

561

4315

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

6.6

8.6

D07AD01

ATC

clobetasol; topical

1.2

8.6

1237

10435

R01AD08

ATC

fluticasone; nasal

1.2

8.6

2184

19349

369

Kela drug reimbursment

Regorafenib

3.5

8.6

L50.0

ICD-10 Finland

Allergic urticaria

1.6

8.6

178

1104

352

Kela drug reimbursment

Abiraterone and enzalutamide

2.5

8.6

216

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.7

8.6

146

860

HAD20

NOMESCO Finland

Liposuction of breast

3.9

8.6

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.2

8.6

303

S29

ICPC

Skin symptom/complaint other

1.2

8.6

1440

12330

K29.8

ICD-10 Finland

Duodenitis

2.2

8.6

297

2AX04, ,

NOMESCO Finland

8.2

8.6

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.6

8.6

183

1144

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

8.5

130

742

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

2.1

8.5

349

L01XE08

ATC

[U] nilotinib

16.3

8.5

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.7

8.5

134

772

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

8.5

962

7920

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.4

8.5

229

XW000, ,

SPAT

9.0

8.5

M79.6

ICD-10 Finland

Pain in limb

1.1

8.5

3368

30795

JJB10

NOMESCO Finland

Atypcal resection of liver

3.8

8.5

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.2

8.5

298

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

8.5

734

5861

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.1

8.5

337

D46

ICD-10 Finland

Myelodysplastic syndromes

27.5

8.5

2AX05, ,

NOMESCO Finland

27.5

8.5

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

3.1

8.5

105

1XC07, ,

NOMESCO Finland

3.4

8.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

2.6

8.5

182

C91

ICD-10 Finland

Lymphoid leukaemia

20.0

8.5

WA010

NOMESCO Finland

Adjuvant whole body radiotherapy

20.0

8.5

L03AA10

ATC

lenograstim; parenteral

20.0

8.5

Z31.6

ICD-10 Finland

General counselling and advice on procreation

2.4

8.5

242

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

432

539

8.33

323.31

3.3

2.5

633.67

498.96

e6/l

0.82

352

449

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

296

218

13.96

319.51

2.4

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

429

540

8.25

318.65

3.4

2.5

696.26

674.39

e6/l

0.07

407

520

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

430

552

8.09

314.16

1.5

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

701

1476

5.03

312.65

1.4

1.3

257.97

272.34

u/ml

0.60

457

904

(40758558) Short blood count panel - Blood

3790

21292

2.25

310.36

18.0

6.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1281

3669

3.86

307.65

2.2

1.6

1.38

1.57

g/l

8.17

1089

3133

(3023520) Reticulocytes [#/volume] in Blood

2744

6768

5.20

307.65

4.6

2.4

72.06

69.58

e9/l

2.21

2116

5094

(3021440) Promyelocytes/100 leukocytes in Blood

2372

6533

4.44

307.65

7.4

3.9

0.18

0.10

4.23

1478

1894

(3016228) CD19 cells/100 cells in Blood

344

290

12.25

307.65

2.5

1.9

7.73

8.55

0.37

337

280

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2855

11247

3.15

307.65

3.0

2.6

24.50

22.49

8.64

2544

9571

(3017143) Hepatitis C virus Ab [Presence] in Serum

2158

8898

2.82

307.65

1.7

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

7531

42907

4.02

307.65

12.5

5.8

2.45

1.91

e9/l

8.73

6988

37712

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8567

64402

3.25

307.65

17.8

7.4

84.18

78.48

u/l

20.22

8353

60670

(3045142) Bone marrow Pathology biopsy report

1337

681

22.49

307.65

1.4

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

618

623

10.50

307.65

2.7

2.3

35.42

39.46

5.43

612

610

(3004809) Band form neutrophils/100 leukocytes in Blood

918

1255

7.95

307.65

5.5

3.0

1.69

1.47

0.85

850

1111

(3002179) Metamyelocytes/100 leukocytes in Blood

2326

6262

4.53

307.65

7.1

3.7

0.81

0.67

2.11

1462

1922

(3018010) Neutrophils/100 leukocytes in Blood

7290

39734

4.04

307.65

12.6

5.8

54.05

57.28

57.94

7011

37140

(3006315) Basophils [#/volume] in Blood

7471

41836

4.07

307.65

12.2

5.7

0.05

0.04

e9/l

1.72

6808

35899

(3008757) Leukocyte morphology finding [Identifier] in Blood

553

854

6.79

307.65

6.9

3.5

—

(3000012) Reticulocyte production index

650

1089

6.31

307.65

3.5

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6134

37897

2.59

307.65

11.0

6.0

1.21

mmol/l

0.29

5792

34547

(1175426) CD3 cells/100 lymphocytes in Blood

583

586

10.50

307.65

2.6

2.1

72.23

71.88

0.14

562

557

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

978

751

14.32

307.65

1.1

—

(3021589) Normoblasts [#/volume] in Blood

5968

36818

2.53

307.65

21.6

9.3

0.01

0.00

e9/l

4.54

5136

29891

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

802

1566

5.48

307.65

1.5

1.4

21.31

18.61

u/ml

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2253

6148

4.43

307.65

4.1

2.6

9.82

10.59

g/l

9.04

2100

5621

(21494434) Karyotype in Bone marrow

959

544

19.38

307.65

1.2

—

(3010503) CD19 cells [#/volume] in Blood

458

439

10.88

307.65

3.2

2.4

0.46

0.19

e9/l

0.77

446

423

(4035726) Immunohistochemistry procedure

2089

7361

3.32

307.65

1.6

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1597

1116

16.83

307.65

1.9

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1676

5583

3.40

307.65

2.9

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

584

845

7.28

307.65

2.0

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3151

13499

2.94

307.65

7.2

3.3

0.80

0.82

mmol/l

11.55

3038

12632

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1103

1540

7.92

307.65

7.5

5.3

1849.49

1430.48

iu/ml

0.11

160

224

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

988

1850

5.81

307.65

2.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

970

1796

5.87

307.65

2.5

1.5

—

(3001604) Monocytes [#/volume] in Blood

7450

41730

4.04

307.65

12.3

5.7

0.61

0.59

e9/l

2.11

6790

35845

(3000093) Morphology [Interpretation] in Blood Narrative

551

736

7.86

307.65

1.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2219

8991

2.88

307.65

2.4

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1694

5891

3.26

307.65

2.3

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

8133

48276

4.60

307.65

24.7

8.7

3.82

4.11

e9/l

13.89

7593

41905

(3023368) Bacteria identified in Blood by Culture

4812

22230

3.24

307.65

7.8

4.2

—

(3025159) Blasts/100 leukocytes in Blood

2198

6197

4.26

307.65

7.5

3.9

0.37

0.39

0.03

1304

1574

(3026493) Urate [Moles/volume] in Serum or Plasma

3914

21895

2.29

307.65

4.9

2.6

1948.31

4396.25

umol/l

6.24

3593

19083

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2518

10870

2.76

307.65

9.3

5.9

1.05

1.04

mmol/l

0.50

2408

10102

(3002030) Lymphocytes/100 leukocytes in Blood

7475

40299

4.34

307.65

13.6

6.0

29.67

27.84

21.94

7207

37714

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1026

2333

4.78

307.65

3.7

2.7

3.38

3.61

g/l

4.71

988

2207

(3022096) Basophils/100 leukocytes in Blood

7256

37807

4.31

307.65

13.2

5.9

0.72

0.68

6.24

6995

35158

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7312

43334

3.53

307.65

13.9

6.0

11.17

11.48

umol/l

1.14

7125

41075

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

954

1786

5.80

307.65

1.9

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

7470

39108

4.55

307.65

15.3

6.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3036

13007

2.91

307.65

3.0

2.5

13.45

12.99

umol/l

2.37

2886

12114

(3019069) Monocytes/100 leukocytes in Blood

7428

39250

4.43

307.65

14.0

6.2

9.16

8.60

22.07

7162

36651

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

671

1025

6.94

307.65

2.0

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

338

280

12.46

307.65

2.5

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

575

574

10.56

307.65

2.6

2.1

13.85

15.81

2.83

561

555

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

823

1314

6.73

307.65

2.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

559

539

10.92

307.65

2.6

2.1

—

(3018418) pH of Serum or Plasma

4625

24602

2.63

307.65

8.0

3.9

7.40

0.03

1303

4643

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

807

1569

5.51

307.65

1.5

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

762

1564

5.19

307.65

1.4

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3034

13189

2.86

307.65

2.7

1.8

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1834

4766

4.48

307.65

2.4

1.8

1.29

1.35

g/l

0.47

1685

4347

(3013115) Eosinophils [#/volume] in Blood

7581

43191

4.08

307.65

13.5

5.9

0.20

0.19

e9/l

0.25

6955

37675

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2937

12020

3.04

307.65

2.9

2.5

2.28

2.34

g/l

5.14

2774

11124

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2207

9014

2.86

307.65

2.4

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4003

9066

6.68

307.65

8.1

3.9

256.86

240.62

u/l

6.44

3863

8527

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1624

5714

3.20

307.65

1.5

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

7379

39034

4.36

307.65

13.3

5.9

2.77

2.87

2.06

7117

36383

(3027945) Reticulocytes/100 erythrocytes in Blood

3347

9057

5.04

307.65

4.5

2.4

1.79

1.77

0.60

3080

7971

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

903

1170

8.38

307.65

3.8

2.8

17782.51

1870.27

u/ml

1.06

(3020630) Protein [Mass/volume] in Serum or Plasma

1918

6799

3.25

307.65

3.3

2.6

65.61

66.51

g/l

4.59

1793

6168

(3011412) CD3 cells [#/volume] in Blood

695

732

10.13

307.65

3.0

2.4

1.24

1.17

e9/l

0.20

628

649

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1150

1121

11.46

307.65

1.3

1.2

47.08

33.97

u/l

1.29

1017

974

(3024561) Albumin [Mass/volume] in Serum or Plasma

5837

36132

2.47

307.65

8.3

4.8

34.11

35.54

g/l

59.88

5534

33544

(3017181) Myelocytes/100 leukocytes in Blood

2586

6849

4.74

307.65

7.3

3.9

1.15

0.90

4.50

1690

2204

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

743

1415

5.59

307.65

1.6

1.5

106.16

116.78

u/ml

1.31

156

296

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6608

41780

2.70

307.65

12.5

6.7

1.21

mmol/l

1.50

5373

35550

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

412

522

8.19

304.27

3.4

2.6

0.20

0.23

e9/l

1.85

349

448

(46235355) HIV 1 and 2 tests - Meaningful Use set

2688

13154

2.42

302.87

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

580

1063

5.73

302.00

1.8

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

888

2320

4.10

301.15

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

662

1370

5.10

301.08

1.9

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2380

11060

2.51

299.93

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

630

1277

5.20

293.35

2.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

630

1277

5.20

293.35

2.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

4219

25396

2.14

283.96

4.3

3.3

88.72

87.56

e6/l

0.02

3491

19457

(3022217) INR in Platelet poor plasma by Coagulation assay

5744

38916

2.11

281.48

16.3

14.9

1.24

1.26

inr

1.33

2145

11142

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1034

3226

3.46

269.53

2.5

1.9

1.78

2.26

ug/l

0.71

959

2839

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

901

2571

3.75

268.89

3.8

3.3

42.77

49.04

mg/l

0.42

715

2084

(3034860) Kappa light chains.free [Mass/volume] in Serum

901

2571

3.75

268.89

3.8

3.3

54.43

77.78

mg/l

0.49

714

2080

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

886

2502

3.79

268.45

3.7

3.2

3.17

2.82

ratio

0.09

196

(3026782) Osmolality of Urine

3082

16705

2.22

267.75

3.6

2.9

517.58

542.79

mosm/kgh2o

9.13

2760

14329

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2567

12905

2.33

267.31

3.5

2.1

30.37

29.85

3.31

2507

12524

(3000850) Epithelial cells [#/volume] in Urine

3201

17676

2.19

264.90

3.4

2.6

5.97

5.38

e6/l

1.04

2944

15843

(3013826) Glucose [Moles/volume] in Serum or Plasma

6721

49058

2.12

260.49

8.2

4.7

6.69

6.72

mmol/l

0.43

6479

45883

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

879

2524

3.72

259.66

3.9

2.5

90.02

91.84

1.35

841

2435

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

312

347

9.25

255.51

2.1

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

308

338

9.37

254.82

5.2

3.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3573

20843

2.11

254.43

2.7

2.3

3.38

2.93

mg/l

12.66

3125

17808

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

311

347

9.22

254.06

2.1

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

3868

23328

2.07

251.04

4.1

3.2

0.45

0.43

e6/l

0.26

3180

17726

(36304419) Bacteria [Presence] in Urine

3787

22680

2.08

250.35

4.0

3.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

390

585

6.90

247.72

1.7

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5209

35182

2.00

243.68

4.1

2.8

259.96

128.74

ug/l

24.41

4879

32500

(3042936) Bacteria identified in Isolate by Culture

2337

11722

2.29

241.48

2.3

2.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

394

619

6.58

239.42

1.7

1.9

3.99

4.15

mg/l

0.25

370

592

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1605

6818

2.61

239.17

7.5

3.7

1.22

1.23

mmol/l

3.20

1485

5963

(3018095) Leukocytes [#/volume] in Urine

4564

29605

1.99

237.98

5.1

3.7

103.60

94.97

e6/l

0.23

3614

20931

(3015377) Calcium [Moles/volume] in Serum or Plasma

4382

28097

1.99

235.51

6.1

3.3

2.34

2.36

mmol/l

14.30

4027

24595

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2020

9608

2.38

235.50

5.1

2.7

9.53

8.25

umol/l

1.38

1801

8327

(3007164) IgA [Mass/volume] in Serum or Plasma

2878

15900

2.14

232.50

2.1

1.5

2.25

2.45

g/l

5.05

2103

9465

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

548

1201

4.77

231.99

1.8

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

507

1045

5.06

230.87

1.8

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

378

592

6.60

230.34

2.0

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

861

2669

3.43

225.46

3.4

2.3

1.42

0.91

g/l

2.06

761

2281

(3033658) Prothrombin time (PT) actual/Normal

3556

21456

2.02

224.63

7.2

4.0

87.36

89.98

8.05

3455

20936

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

446

841

5.50

224.50

2.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

651

1682

4.07

222.72

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

435

809

5.57

222.26

5.9

3.0

49.10

58.07

10.81

375

692

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

415

742

5.79

221.17

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

153

25.45

219.34

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

423

780

5.62

218.10

2.5

2.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

945

3167

3.19

217.73

3.1

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

944

3162

3.19

217.69

3.1

2.3

3.64

3.69

g/l

0.29

876

2840

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

945

3169

3.19

217.49

3.1

2.3

7.06

7.45

g/l

8.57

877

2846

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

903

2958

3.26

216.06

3.1

2.3

3.02

2.93

g/l

1.62

834

2638

(40768795) Lymph node Pathology biopsy report

417

772

5.59

214.06

1.4

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

415

769

5.59

212.81

2.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

776

2348

3.50

210.66

3.2

2.2

0.05

0.04

g/l

0.19

719

2137

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4171

27050

1.93

209.75

5.5

3.2

36.75

34.60

u/l

0.96

4005

25590

(40760888) Immunoglobulin light chains.free panel - Serum

693

1961

3.72

208.11

3.5

3.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

634

1697

3.92

206.24

1.7

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1654

7605

2.41

205.67

2.6

2.2

364.25

374.13

nmol/l

1.04

1570

6981

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

179

118

15.43

205.18

1.2

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

874

2946

3.15

198.85

3.1

2.3

10.37

10.21

g/l

0.37

801

2600

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

301

433

7.14

198.50

3.3

2.6

36.85

40.21

1.58

162

248

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1682

7933

2.35

196.68

2.7

2.3

0.20

0.21

g/l

4.07

1559

7388

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

721

2182

3.48

195.34

3.1

2.2

0.00

g/l

0.33

664

1977

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

428

881

5.03

194.89

2.0

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

428

881

5.03

194.89

2.0

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

311

476

6.71

193.56

1.9

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

748

2340

3.37

192.27

1.7

1.2

—

(40765096) Chromosome analysis panel by Banding

212

205

10.54

192.15

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

727

2246

3.41

190.59

6.5

4.1

1.51

1.52

mg/l

0.15

678

2072

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

250

304

8.41

190.58

2.6

2.3

31.35

28.06

1.93

236

285

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

706

2144

3.47

190.14

3.2

2.2

0.00

g/l

-0.00

664

1968

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

288

415

7.11

189.60

2.0

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

764

2443

3.30

189.50

3.1

2.1

37.63

37.76

g/l

0.21

694

2115

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1745

8486

2.28

189.27

5.2

3.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4007

26301

1.87

188.56

3.4

2.6

54.16

62.90

u/l

2.12

3767

24234

(3006245) CD3-CD19+ cells/100 cells in Blood

251

312

8.23

187.91

2.8

2.5

13.08

11.12

0.85

230

289

(3020779) Urea [Moles/volume] in Serum or Plasma

1589

7451

2.35

187.61

11.6

7.4

9.80

9.78

mmol/l

0.03

1522

7103

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

288

420

7.03

187.52

2.0

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

735

2315

3.35

186.76

3.7

2.7

196.72

192.78

0.54

707

2203

(40761536) Microorganisms panel - Urine sediment

1505

6918

2.38

185.85

5.0

4.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

395

797

5.12

183.99

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2107

11216

2.11

181.30

1.5

1.3

602.04

532.12

titre

0.80

470

2347

(3048879) Bone marrow aspiration report

202

203

10.13

178.14

2.4

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6969

54829

1.89

177.48

5.8

4.5

708.06

1614.01

e6/l

1.41

158

744

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

803

2765

3.07

175.51

2.6

2.7

—

(3044640) Blood type and Crossmatch panel - Blood

3987

26603

1.83

174.16

4.9

2.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

130

20.89

172.47

2.3

4.0

1.41

1.51

mg/l

0.08

(3000060) B lymphocytes [#/volume] in Blood

204

222

9.36

169.64

2.8

2.5

1381.32

219.60

e6/l

1.07

121

124

(3009445) Proteinase 3 Ab [Units/volume] in Serum

942

3610

2.78

169.16

1.5

1.6

13.50

17.05

u/ml

0.32

103

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1735

8799

2.17

167.92

4.8

4.1

24.34

27.08

ug/l

0.15

1417

7147

(3036489) Thrombin time

840

3075

2.89

164.24

3.4

2.2

22.03

21.48

1.91

771

2682

(3013707) Erythrocyte sedimentation rate by Westergren method

7580

61979

1.91

162.34

6.3

4.1

15.38

12.20

mm/h

41.00

7146

57322

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5315

39151

1.76

161.53

4.6

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

714

2430

3.09

158.86

1.8

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2937

18239

1.86

158.52

2.5

1.8

1.61

1.20

mg/l

5.90

2327

13906

(3037467) Urinalysis macro (dipstick) panel - Urine

7117

57411

1.82

154.51

5.8

4.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

105

25.25

150.17

5.2

4.4

—

(3012501) Base excess in Blood by calculation

590

1865

3.30

148.38

5.1

4.1

2.50

mmol/l

0.01

423

1266

(3013290) Carbon dioxide [Partial pressure] in Blood

590

1867

3.29

148.12

5.1

4.1

4.98

4.99

kpa

0.14

577

1831

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1164

5249

2.38

148.07

10.3

7.5

24.85

24.80

mmol/l

0.21

1149

5214

(3027315) Oxygen [Partial pressure] in Blood

592

1879

3.29

147.89

5.1

4.1

8.52

8.64

kpa

0.76

579

1842

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

324

666

4.99

147.52

3.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

324

666

4.99

147.52

3.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

324

666

4.99

147.52

3.0

1.5

—

(1616796) Gas panel - Central venous blood

580

1836

3.29

145.48

4.5

3.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

153

138

11.24

145.33

3.2

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

276

502

5.62

144.12

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

755

2834

2.80

140.25

1.8

1.6

475.44

255.21

titre

0.76

119

(3010421) pH of Blood

636

2183

3.04

139.04

5.2

4.1

7.42

1.88

592

1979

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

634

2186

3.03

137.48

1.9

2.0

12.27

11.07

mg/l

1.14

583

2023

(3021960) Folate [Moles/volume] in Serum or Plasma

2967

19213

1.77

135.27

1.8

1.5

20.17

20.40

nmol/l

0.33

2677

16375

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

115

15.10

130.59

1.3

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1771

9869

1.96

129.49

2.0

1.8

—

(3024471) HLA-A [Type]

183

247

7.53

127.63

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

729

2822

2.71

127.29

4.6

3.2

0.33

0.34

u/ml

0.58

460

1602

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

667

2468

2.82

127.01

2.1

1.6

0.22

0.24

g/l

5.50

621

2338

(3026008) Bacteria identified in Urine by Culture

3662

25486

1.69

126.78

3.5

3.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3447

23673

1.69

125.03

3.7

3.0

1711.91

1374.49

ng/l

2.97

3018

20352

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

675

2546

2.77

123.87

2.1

1.6

1.13

1.19

g/l

4.73

636

2412

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

39.76

123.16

9.5

7.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

171

225

7.71

121.93

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

173

231

7.60

121.79

4.3

2.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

183

262

7.10

121.08

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

183

263

7.07

120.66

2.0

1.9

500.72

23960.95

u/ml

0.88

(3032868) Hemoglobin electrophoresis panel in Blood

17.80

119.80

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

123

108

11.52

118.89

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

529

1786

3.07

118.72

3.2

2.5

15.75

16.37

1.96

286

923

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1019

4751

2.27

118.68

1.7

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2447

15479

1.77

118.19

1.9

1.7

1215.37

1165.81

nmol/l

1.77

1930

11647

(3024980) IgG subclass 4 [Mass/volume] in Serum

443

1351

3.38

117.68

1.6

0.84

0.77

g/l

0.36

315

1026

(4212803) Bone marrow aspirate examination

102

15.37

116.99

1.1

—

(3024932) HLA-DR beta [Type]

173

245

7.17

115.60

1.3

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

610

2285

2.78

113.23

1.5

1.4

14.68

13.91

iu/ml

0.05

(3016650) Hepatitis A virus Ab [Presence] in Serum

428

1310

3.37

113.00

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

155

202

7.78

111.43

2.4

1.9

60.14

34.94

u/l

0.73

149

183

(3000494) Fungus identified in Specimen by Culture

1698

9763

1.89

111.37

1.9

1.4

—

(3000991) Gas panel - Venous blood

1342

7124

2.02

111.36

11.1

8.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

379

1084

3.59

111.14

7.3

6.2

11.66

11.57

mg/l

0.14

355

996

(3042631) Mycobacterium sp identified in Specimen

380

1091

3.58

110.79

2.5

2.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4241

31509

1.60

108.02

4.6

3.6

57.28

69.63

ng/l

0.22

3256

21600

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

505

1753

2.98

107.80

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1058

5208

2.15

107.23

5.9

3.9

2.12

1.75

mmol/l

2.51

779

3862

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

504

1753

2.97

107.20

1.6

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1419

7782

1.96

106.96

7.0

4.1

5.75

5.84

kpa

2.63

1374

7553

(3009343) pH of Capillary blood

1083

5393

2.13

106.51

6.0

3.9

7.42

1.45

222

648

(3002032) Base excess in Venous blood by calculation

1413

7753

1.96

106.30

7.0

4.1

1.88

1.89

mmol/l

0.03

1198

6570

(3021601) Nitrite [Presence] in Urine by Test strip

5213

40765

1.58

105.79

6.1

4.9

0.00

estimate

0.80

1601

7472

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

431

1381

3.22

105.56

5.5

3.6

55.75

32.24

u/ml

1.31

424

1340

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

185

309

6.08

105.54

4.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

184

306

6.11

105.43

4.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

184

306

6.11

105.43

4.0

1.8

—

(3012544) pH of Venous blood

1451

8062

1.93

105.09

7.0

4.1

7.38

7.37

0.16

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

211

401

5.35

104.97

3.7

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

211

401

5.35

104.97

3.7

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

5205

40752

1.58

104.57

4.7

3.7

0.00

estimate

3.18

1633

7926

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1086

5460

2.11

104.04

6.0

3.9

5.08

5.15

kpa

1.54

1026

5190

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

419

1332

3.24

103.96

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1347

7323

1.97

103.93

9.1

7.0

1.41

1.33

mmol/l

1.44

1323

7126

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4550

34581

1.58

103.75

2.9

2.2

76.89

77.46

nmol/l

0.70

4200

31089

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2964

20350

1.65

103.18

4.7

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

997

4865

2.16

103.15

2.2

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

5245

41216

1.57

103.09

4.7

3.7

0.00

estimate

0.20

1546

7278

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

790

3503

2.36

102.92

1.9

41.45

39.01

u/l

2.02

700

3081

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

197

360

5.56

102.30

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4500

34216

1.57

101.71

2.2

2.0

92.45

95.88

pmol/l

5.21

2678

17671

(3015235) Bicarbonate [Moles/volume] in Capillary blood

551

2074

2.75

101.14

4.2

3.1

24.71

24.80

mmol/l

0.18

536

2037

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9165

83392

2.13

99.83

33.8

14.1

24.56

23.92

mg/l

1.14

8209

66113

(3028626) Oxygen [Partial pressure] in Capillary blood

544

2069

2.72

97.82

6.7

4.0

8.26

8.38

kpa

0.88

529

2024

(4062490) Immunoglobulin typing, IgG

313

864

3.71

96.70

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2099

13370

1.72

96.04

3.8

3.0

2.68

2.53

e6/l

0.29

1207

7262

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

161

258

6.33

95.73

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

3102

21856

1.61

95.67

5.1

4.1

0.00

estimate

2.60

1495

7208

(3021901) Oxygen saturation in Capillary blood

436

1491

3.01

95.45

3.7

2.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2332

15367

1.67

93.67

4.3

3.0

2.46

2.45

mmol/l

1.35

2081

13408

(3041096) Erythrocytes [Presence] in Urine by Automated

3077

21731

1.60

93.50

4.5

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

858

4105

2.19

92.92

8.1

4.5

24.19

24.10

mmol/l

0.39

846

4027

(3024139) IgG subclass 3 [Mass/volume] in Serum

308

864

3.65

92.91

1.4

0.41

g/l

0.10

206

606

(3027135) IgG subclass 1 [Mass/volume] in Serum

308

864

3.65

92.91

1.4

7.35

6.70

g/l

1.07

205

608

(3028192) IgG subclass 2 [Mass/volume] in Serum

308

865

3.64

92.75

1.4

2.60

2.92

g/l

1.94

205

608

(40768804) Tissue Pathology biopsy report

4446

34200

1.54

92.25

2.4

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

154

245

6.37

92.23

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

397

1340

3.04

88.88

2.3

1.9

1.71

mmol/l

0.01

384

1311

(3032352) Blasts [#/volume] in Cerebral spinal fluid

12.15

88.17

4.0

3.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

583

2428

2.49

86.92

1.4

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1578

9519

1.78

86.50

9.1

7.2

11.88

12.42

kpa

3.80

1522

9070

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1577

9523

1.78

86.10

9.2

7.2

5.07

5.09

kpa

0.35

1518

9082

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

122

8.85

85.80

1.7

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

972

5044

2.03

84.65

1.8

1.3

332.95

223.19

u/ml

1.62

883

4659

(3003396) Base excess in Arterial blood by calculation

1566

9492

1.77

84.25

9.2

7.2

1.32

1.04

mmol/l

1.87

1271

7556

(3017732) Neutrophils [#/volume] in Blood

1064

5735

1.96

83.07

4.3

2.9

4.93

4.97

e9/l

0.03

843

4593

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

16.39

83.03

3.0

3.1

—

(3025941) Bacteria identified in Stool by Culture

897

4552

2.07

82.99

1.4

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

437

1616

2.78

82.79

1.4

1.2

104.44

172.63

titre

—

(3022806) Fractional oxyhemoglobin in Capillary blood

336

1072

3.21

82.76

2.3

1.8

88.67

89.96

2.33

328

1055

(3026250) Tacrolimus [Mass/volume] in Blood

175

353

5.03

81.39

36.6

34.1

7.56

7.30

ug/l

0.51

158

320

(3010375) cycloSPORINE [Mass/volume] in Blood

182

380

4.86

81.29

33.3

26.1

129.44

113.71

ug/l

2.02

152

318

(3016502) Oxygen saturation in Arterial blood

1425

8508

1.79

80.41

9.6

7.6

95.11

95.69

2.50

1380

8190

(3013862) HLA-DP [Type]

27.14

79.10

1.0

—

(46236302) HLA-C [Type] by High resolution typing

26.63

77.13

1.0

—

(40763590) HLA-DQ beta [Type]

26.63

77.13

1.0

—

(40760409) HLA-A [Type] by High resolution

26.63

77.13

1.0

—

(40760410) HLA-B [Type] by High resolution

26.63

77.13

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

320

1036

3.16

76.90

1.2

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3405

25449

1.51

76.61

2.7

2.1

181.11

221.17

u/l

1.68

3201

23848

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

13.18

75.82

1.1

—

(3023419) Bacteria identified in Sputum by Culture

357

1241

2.95

75.80

2.4

2.6

—

(3002385) Erythrocyte distribution width [Ratio]

8042

71749

1.61

74.88

39.9

16.7

15.30

15.03

2.74

7978

70475

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

8.48

73.67

1.8

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

488

2024

2.48

73.23

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2128

14457

1.60

72.95

3.6

2.8

1.05

1.36

e6/l

0.82

1245

8300

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1322

7947

1.76

72.30

3.2

2.4

33.45

44.26

u/l

1.09

1172

6789

(3034770) Mitochondria Ab [Titer] in Serum

531

2302

2.38

72.27

1.2

753.85

891.33

titre

0.25

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

365

1318

2.84

72.27

1.2

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

24.40

71.90

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

20.88

71.59

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.51

71.22

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

571

2571

2.29

71.19

4.1

3.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

528

2318

2.35

69.80

1.3

1.2

154.60

153.51

titre

0.01

205

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

140

278

5.09

66.34

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1287

7857

1.73

66.25

10.3

7.9

116.70

121.57

g/l

11.39

1254

7642

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

29.46

66.14

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

551

2520

2.26

66.11

1.6

0.26

4.23

iu/ml

0.96

112

551

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2294

16165

1.54

66.04

4.2

3.8

484.55

484.97

ng/l

0.00

1838

12586

(3023183) Ammonium ion [Moles/volume] in Plasma

428

1763

2.49

65.11

3.8

2.8

35.45

34.17

umol/l

0.48

394

1595

(3001964) Herpes simplex virus Ag [Presence] in Specimen

125

228

5.54

65.10

1.9

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9191

85723

1.85

63.30

33.5

16.2

139.24

139.69

mmol/l

53.46

9057

83655

(3024354) Oxygen [Partial pressure] in Venous blood

1088

6421

1.78

62.85

6.6

3.5

4.76

4.62

kpa

1.20

1047

6212

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3947

31251

1.43

62.38

4.9

3.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

350

1337

2.68

62.16

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

17.94

61.95

2.1

1.2

—

(3044889) 12 lead EKG panel

6712

58476

1.45

61.92

4.8

3.8

—

(3028433) Virus identified in Specimen by Culture

134

273

4.96

61.66

1.3

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

123

233

5.33

61.48

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6345

54751

1.43

61.38

4.5

3.1

66.15

48.16

u/l

22.44

5970

50909

(40768797) Stomach Pathology biopsy report

1745

11727

1.59

61.32

1.3

1.2

—

(3019060) Gas panel - Arterial blood

949

5433

1.82

60.58

6.1

4.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9197

85968

1.83

60.44

34.5

16.4

3.97

mmol/l

0.56

9051

83726

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

429

1864

2.36

57.96

2.1

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

435

1905

2.34

57.72

2.6

2.2

125.47

130.07

g/l

2.27

352

1366

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

263

899

2.98

57.53

1.2

81.53

63.85

u/l

0.93

244

794

(3015736) pH of Urine

4084

32881

1.41

57.13

4.0

3.4

5.85

5.86

0.02

200

2383

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

529

2523

2.16

57.10

2.2

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

465

2110

2.26

56.76

1.4

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

325

4.42

56.73

1.5

863369.20

1276929.44

iu/ml

—

(40768806) Pleura Pathology biopsy report

255

869

2.98

56.09

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

220

692

3.23

55.49

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

251

857

2.98

55.03

2.1

—

(3002256) Pathology report gross observation

1623

10972

1.57

54.97

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

660

3469

1.97

54.66

3.3

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

545

2676

2.10

54.51

1.9

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

283

1038

2.78

54.39

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

316

1232

2.62

53.87

1.3

1.2

3.93

3.74

u/ml

0.04

126

406

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

304

1163

2.66

53.83

3.3

2.6

132.07

1370.94

u/ml

0.88

296

1150

(3015171) Extractable nuclear Ab [Units/volume] in Serum

624

3262

1.97

52.45

1.3

0.37

1.04

u/ml

2.33

313

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

762

4263

1.85

52.13

6.5

3.5

50.91

56.70

u/ml

0.43

737

4103

(3003694) ABO and Rh group [Type] in Blood

2935

22616

1.42

51.32

1.6

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

587

3037

1.99

50.80

3.8

3.5

1428.59

2078.15

u/ml

0.18

513

2603

(3012441) Differential panel - Pleural fluid

241

846

2.89

50.28

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

303

1199

2.57

50.11

1.3

1.2

4.75

4.28

u/ml

0.22

146

530

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

772

4394

1.82

49.89

11.0

9.2

24.37

24.30

mmol/l

0.22

756

4258

(3014148) Varicella zoster virus Ab [Titer] in Serum

259

956

2.75

49.19

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

400

3.79

48.80

2.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

400

3.79

48.80

2.2

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

282

1102

2.60

47.86

1.5

33.89

32.55

g/l

0.99

255

992

(3047189) Immunofixation for 24 hour Urine

147

393

3.78

47.66

1.6

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

203

667

3.09

47.62

1.2

192.06

213.02

titre

0.12

129

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

203

667

3.09

47.62

1.2

234.29

216.96

titre

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

160

455

3.56

47.36

2.9

2.5

92.87

97.44

0.72

155

424

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

374

1671

2.29

47.32

1.2

—

(3022145) Colonoscopy Study observation

1395

9407

1.56

47.13

1.4

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8466

78404

1.51

46.91

29.6

13.2

80.64

80.83

ml/min/173m2

0.33

7565

64859

(40768441) Liver Pathology biopsy report

191

615

3.15

46.38

1.6

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

152

5.70

46.38

1.4

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

875

5277

1.72

46.19

11.3

9.0

93.50

93.97

1.53

867

5258

(3019420) Tryptase [Mass/volume] in Serum or Plasma

149

415

3.63

45.52

1.9

1.5

10.92

8.12

ug/l

0.88

133

372

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

173

535

3.27

44.92

2.1

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

439

2144

2.10

44.46

1.6

1.4

10.72

10.50

u/l

0.11

356

1719

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

586

3174

1.90

44.20

2.4

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

276

1113

2.52

43.90

1.1

1.61

1.51

g/l

2.78

253

998

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

174

549

3.21

43.73

2.1

1.3

—

(3051651) Icteric interference index of Serum or Plasma

169

524

3.26

43.71

4.9

3.4

—

(40768793) Breast Pathology biopsy report

391

1840

2.17

43.58

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

365

1675

2.22

43.31

2.3

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1004

6381

1.64

43.30

5.0

3.9

98.90

90.87

ng/l

1.58

886

5489

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

858

5247

1.69

42.92

11.4

8.9

0.69

0.67

0.76

849

5211

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

267

1072

2.53

42.87

2.5

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

545

2912

1.92

42.82

2.8

2.3

508.03

556.46

ug/l

0.10

514

2739

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

382

1794

2.17

42.79

2.3

1.5

40.31

25.11

e6/l

0.21

317

1368

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

382

1795

2.17

42.73

2.3

1.5

504.97

1221.75

e6/l

1.77

335

1448

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

420

2049

2.10

42.65

2.0

1.4

602.41

528.85

mg/l

0.55

403

1941

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2339

17795

1.41

42.43

1.7

30376967.54

32152708.10

pmol/l

0.05

1939

14789

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

765

4552

1.74

42.26

12.3

9.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

354

1621

2.23

42.22

1.7

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

1079

2.51

41.80

2.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

269

1097

2.49

41.80

2.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

264

1068

2.51

41.72

2.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

264

1070

2.51

41.56

2.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

854

5264

1.68

41.42

11.4

8.8

1.40

1.36

0.47

846

5230

(3005988) Vibrio sp identified in Specimen by Organism specific culture

264

1073

2.50

41.32

2.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

166

529

3.17

41.06

1.2

1.1

—

(3022313) Gas panel - Capillary blood

684

3994

1.76

40.33

7.1

4.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

275

1162

2.40

39.56

1.1

113.74

117.19

0.85

247

1046

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

214

804

2.70

39.33

3.6

2.9

—

(3003181) Sodium [Moles/volume] in Urine

322

1465

2.24

39.02

1.6

1.4

63.92

64.32

mmol/l

0.06

253

1181

(3035637) Corticotropin [Mass/volume] in Plasma

263

1097

2.43

38.94

1.6

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

203

747

2.75

38.84

1.3

685.88

352.29

u/l

0.74

192

707

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

370

1797

2.10

38.01

2.0

1.4

3.80

3.78

mmol/l

0.08

352

1680

(3008152) Bicarbonate [Moles/volume] in Arterial blood

828

5183

1.65

37.72

9.2

7.1

24.77

24.60

mmol/l

0.61

794

4932

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7044

63933

1.34

37.35

4.6

4.0

14.88

14.79

pmol/l

1.98

6466

58119

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

333

3.63

36.93

4.1

4.7

1835.14

65.62

mg/l

0.49

104

235

(3042733) HLA Ab [Presence] in Serum

104

261

4.02

36.92

5.3

4.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

104

6.09

36.48

1.2

1.3

—

(3008295) Osmolality of Serum or Plasma

216

853

2.57

35.94

1.5

1.4

277.40

279.82

mosm/kgh2o

0.79

182

651

(3013512) EKG study

3011

24364

1.34

35.94

4.5

3.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

359

1764

2.07

35.76

3.9

3.5

237.66

634.99

u/ml

1.39

328

1614

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

136

420

3.27

35.48

1.2

1.1

34.53

25.90

u/l

0.79

126

373

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

136

422

3.25

35.21

1.2

1.1

99.02

85.54

u/l

0.93

127

377

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

804

5083

1.63

35.13

3.2

3.3

4.46

4.47

pmol/l

0.05

685

4506

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

199

765

2.63

34.99

1.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

204

4.34

34.71

1.3

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

166

583

2.88

34.71

1.3

14.65

12.49

u/l

0.35

157

537

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

321

1536

2.13

34.30

4.2

3.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

214

862

2.51

34.19

1.9

1.5

29.35

22.56

iu/ml

0.89

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

289

1331

2.21

34.02

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

272

1222

2.26

34.01

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1042

7055

1.53

33.84

3.3

2.9

227.39

193.24

ng/l

1.62

950

6429

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

119

351

3.42

33.42

1.3

1.8

149.90

149.51

0.01

113

329

(21491868) Cryoglobulin [Mass/volume] in Serum

106

290

3.68

33.35

1.3

1.2

0.26

0.22

g/l

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9266

88608

1.59

32.97

23.1

10.3

27.40

26.36

u/l

3.35

9102

85439

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

205

825

2.52

32.83

2.4

2.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

231

983

2.38

32.76

1.5

5900.89

2241.24

e6/l

0.49

182

708

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

1.07

1.64

mg/l

0.40

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

2.16

3.01

mg/l

0.44

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

1.18

0.72

mg/l

0.46

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

0.75

2.00

mg/l

1.23

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

3.07

3.56

mg/l

0.17

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

1.70

0.85

mg/l

0.40

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

2.22

1.55

mg/l

0.19

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

1.30

1.76

mg/l

0.25

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.14

32.42

1.7

1.5

3.53

1.48

mg/l

0.85

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

113

330

3.45

32.24

2.5

2.2

37.77

195.52

ug/l

0.82

107

303

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

133

430

3.12

32.19

1.2

—

(40757373) Influenza virus identified in Isolate

148

4.82

31.94

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

400

2125

1.92

31.93

1.3

13.26

6.75

u/ml

0.83

334

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

150

522

2.90

31.92

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

140

469

3.01

31.88

12.8

18.3

1372.24

1425.24

nmol/l

0.27

131

454

(3000570) Elastase.pancreatic [Mass/mass] in Stool

454

2514

1.84

31.86

1.4

270.84

274.48

ug/g

0.14

285

1470

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.75

31.84

1.7

1.6

1.38

1.25

mg/l

0.07

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

396

2099

1.92

31.83

1.3

9.88

3.26

u/ml

0.66

207

(3013005) Retinol [Moles/volume] in Serum or Plasma

116

348

3.36

31.74

2.4

1.8

1.85

1.93

umol/l

0.43

111

328

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

150

524

2.89

31.70

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

214

894

2.42

31.64

4.6

3.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

167

622

2.71

31.30

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

152

540

2.84

31.16

1.6

6.08

6.89

u/l

0.30

116

431

(40768446) Kidney Pathology biopsy report

112

333

3.39

31.09

1.7

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

180

4.36

30.98

1.4

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

211

887

2.41

30.77

1.5

93839.37

62696.20

e6/l

0.37

137

526

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

207

863

2.43

30.75

1.2

1.1

90.39

96.84

2.49

191

809

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

341

1738

2.00

30.73

1.3

1.2

8.47

3.56

u/ml

0.36

120

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

236

1044

2.29

30.64

1.4

0.26

0.37

nmol/l

2.39

160

798

(3036782) Glucose [Moles/volume] in Pleural fluid

187

746

2.54

30.53

1.4

6.21

6.36

mmol/l

0.30

176

682

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

419

2296

1.86

30.41

1.3

39.96

40.43

u/ml

0.01

144

(3030981) Hyaline casts [#/volume] in Urine by Automated count

692

4371

1.63

30.24

3.9

2.7

0.20

0.29

e6/l

1.84

681

4253

(3006922) Hepatitis E virus Ab [Presence] in Serum

155

568

2.76

29.99

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

214

922

2.35

29.55

2.5

1.34

1.37

g/24h

0.04

118

460

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

338

1742

1.97

29.51

1.3

1.2

2.18

18.08

u/ml

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

165

630

2.65

29.47

1.4

1.3

2.38

2.06

mmol/l

1.16

154

591

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

188

772

2.46

28.89

3.5

3.6

—

(3004451) EKG impression Narrative

121

396

3.08

28.74

1.4

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

150

4.56

28.61

1.3

40.63

133.77

titre

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

576

3527

1.67

28.42

7.7

4.3

24.89

24.78

mmol/l

0.40

531

3262

(3029634) Reagin Ab [Titer] in Serum by VDRL

235

1072

2.22

28.37

1.9

2.0

17.00

2.96

titre

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

144

528

2.75

27.86

1.2

138.15

85.25

u/l

1.13

132

453

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

141

512

2.78

27.79

1.2

32.68

22.38

u/l

1.20

128

426

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

150

564

2.68

27.65

2.4

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

758

4995

1.56

27.63

6.1

3.5

121.83

129.19

g/l

12.11

737

4864

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

120

401

3.02

27.51

1.8

1.3

61.45

64.60

0.14

(3018405) Lactate [Moles/volume] in Arterial blood

492

2914

1.72

27.47

4.9

4.0

1.44

1.38

mmol/l

0.54

481

2867

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

120

404

2.99

27.16

3.8

4.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

130

459

2.86

27.01

9.8

12.6

767.12

836.28

nmol/l

0.92

124

436

(3037121) Protein [Mass/volume] in Urine

487

2895

1.72

26.83

4.1

3.2

0.37

0.30

g/l

0.40

296

1238

(3048689) Calprotectin [Mass/mass] in Stool

1355

10067

1.40

26.77

2.7

2.3

188.52

132.07

ug/g

2.03

1104

7944

(3020891) Body temperature

539

3298

1.67

26.66

5.9

4.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2273

18297

1.31

26.55

1.3

1.22

1.75

u/ml

2.10

578

4827

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

115

383

3.03

26.53

1.2

1.1

23.67

20.29

u/ml

0.06

(3017704) Immunofixation for Urine

125

437

2.88

26.46

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

180

755

2.41

26.44

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

207

923

2.27

26.43

9.1

13.7

7.53

7.36

mmol/l

0.24

181

775

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.59

26.32

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

116

393

2.97

25.98

2.8

5.5

49.13

9186.38

u/ml

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

200

888

2.28

25.81

1.6

1.8

811.43

1522.29

titre

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

617

3942

1.60

25.66

4.9

3.5

25.06

25.22

mmol/l

0.55

595

3816

(40759836) Histone Ab [Presence] in Serum by Immunoblot

152

600

2.56

25.44

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

152

601

2.55

25.35

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

601

2.55

25.35

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

152

604

2.54

25.10

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

152

604

2.54

25.10

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

152

606

2.53

24.93

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

197

887

2.25

24.60

2.4

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

105

4.97

24.34

2.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

880

6147

1.47

24.24

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

246

3.43

23.97

1.5

1.4

1.20

2.74

2.03

206

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

129

490

2.65

23.37

1.2

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

265

3.30

23.35

1.3

1.9

185.44

181.63

0.11

251

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

485

2.66

23.31

1.2

1.1

1.12

1.06

ratio

1.15

165

(3023323) Follitropin [Units/volume] in Serum or Plasma

538

3412

1.61

23.06

1.6

1.4

26.65

29.66

iu/l

1.29

453

2905

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

191

3.74

23.01

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

190

872

2.20

22.68

1.1

—

(3036603) Volume of Urine

142

574

2.49

22.66

1.5

1.6

1851.63

1909.90

0.37

136

555

(3026692) Albumin [Mass/volume] in Peritoneal fluid

207

3.59

22.66

1.6

12.78

13.38

g/l

0.21

166

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

251

3.33

22.55

1.8

1.3

28.68

25.33

0.15

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

517

2.57

22.50

1.4

1.2

—

(21494755) Public health laboratory ask at order entry panel

463

7301

0.62

22.48

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

275

1457

1.91

22.21

1.8

1.9

4.68

5.06

mmol/24h

0.99

249

1274

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

522

2.55

22.07

1.4

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1793

14288

1.31

21.99

1.3

42.85

34.29

iu/ml

0.96

574

4522

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

296

3.09

21.94

1.5

1.4

64.25

64.78

0.05

240

(3012565) Volume of 24 hour Urine

111

404

2.77

21.88

2.1

2.2

1744.74

1949.02

1.19

357

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

564

3662

1.57

21.88

5.4

4.1

48.97

48.45

0.19

559

3616

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.08

21.73

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

162

709

2.31

21.69

1.3

—

titre

—

(40762365) Oxygen content in Arterial blood by calculation

138

4.15

21.38

2.6

2.9

14.71

14.76

ml/dl

0.04

128

(3026389) Candida sp identified in Specimen by Organism specific culture

236

1207

1.98

21.16

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

174

794

2.21

21.10

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

108

396

2.75

21.01

1.1

4.60

3.57

iu/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

190

3.60

20.88

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

394

2369

1.69

20.83

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

136

562

2.44

20.74

1.5

1.3

3.63

1.70

u/ml

0.63

323

(40761511) CBC panel - Blood by Automated count

8977

86323

1.38

20.68

27.7

13.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

396

2389

1.68

20.68

1.3

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

229

1169

1.98

20.65

6.2

5.0

390.41

364.02

umol/l

1.88

200

1002

(3035880) pH of Pleural fluid

117

451

2.61

20.64

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

397

2399

1.68

20.60

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

210

1042

2.04

20.51

1.3

46.68

56.99

u/ml

0.24

(3016038) Potassium [Moles/volume] in Urine

136

565

2.43

20.51

1.6

1.2

31.16

34.60

mmol/l

1.16

118

487

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

252

3.19

20.38

1.9

2.0

16966.51

18401.69

e6/l

0.04

135

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

304

1712

1.80

20.26

1.3

46.52

42.61

u/ml

0.18

171

(3009871) Measles virus Ab [Titer] in Serum

264

3.12

20.15

1.7

—

(3019225) pH of Specimen

1121

8445

1.37

19.99

7.3

4.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

221

3.32

19.84

1.2

1.3

217.70

366.96

ug/l

0.38

126

(3052592) Norovirus Ag [Presence] in Stool

155

3.82

19.82

1.6

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.42

19.61

1.2

—

(40768443) Skin Pathology biopsy report

566

3788

1.52

19.15

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.90

19.13

2.2

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

384

2348

1.66

19.07

3.0

2.2

5807.43

4893.96

u/l

0.14

121

908

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

269

3.03

18.91

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

131

3.98

18.54

6.2

5.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5631

51611

1.21

18.38

3.3

2.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

101

386

2.63

18.18

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

427

2.55

18.15

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

287

2.91

18.06

2.0

2.2

2137.84

3545.84

e6/l

0.18

195

(3024928) Oxygen saturation in Venous blood

297

1732

1.74

17.60

7.7

3.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

341

2.71

17.60

3.2

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8052

76632

1.26

17.57

5.5

4.8

2.30

2.15

mu/l

0.18

7468

70167

(3047181) Lactate [Moles/volume] in Blood

417

2660

1.59

17.47

8.4

6.1

1.41

1.28

mmol/l

0.92

365

2347

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1663

13485

1.28

17.41

1.3

18.48

12.55

u/ml

1.78

549

5184

(3019977) pH of Arterial blood

112

460

2.45

17.39

2.9

2.7

7.44

7.42

2.55

159

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

514

3443

1.52

17.32

7.4

5.2

1.80

1.64

1.93

481

3219

(3007919) Fasciola sp Ab [Titer] in Serum

24.04

17.28

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

210

3.21

17.27

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

116

4.07

17.24

1.2

1.4

492113.92

144337.57

nmol/l

0.31

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

247

3.01

17.16

1.2

95.87

104.62

0.89

225

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

360

2238

1.63

16.78

1.2

1.3

174.67

221.36

miu/ml

1.58

113

1012

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

446

2.44

16.59

1.3

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

249

2.95

16.32

1.2

1.1

76.38

90.47

2.74

114

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

14.24

16.27

1.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

477

6974

0.67

16.13

1.7

—

(3017569) Oxygen content in Arterial blood

398

2.50

16.12

2.6

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

798

5887

1.39

16.09

2.9

2.1

11.81

12.56

nmol/l

1.71

721

5223

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

241

2.96

16.02

1.2

76.53

89.79

1.76

115

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

127

572

2.24

16.01

1.4

12.83

umol/l

0.00

122

539

(3023383) Lactate [Moles/volume] in Pleural fluid

258

2.88

15.92

1.3

3.53

3.34

mmol/l

0.23

229

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1724

14179

1.26

15.91

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

3041

26562

1.21

15.81

3.7

3.2

7.18

7.53

mmol/l

4.18

2533

22373

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

298

2.73

15.77

4.1

2.4

183.23

143.12

nmol/l

2.62

255

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

129

3.73

15.69

2.0

3.0

64.50

43.16

mg/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.15

15.51

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

343

2154

1.61

15.37

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

5.73

15.36

4.1

3.7

4.48

6.51

—

(3046861) Legionella sp Ag [Presence] in Urine

6.42

15.35

1.1

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

384

2480

1.57

15.29

1.8

1.7

340.50

302.60

mu/l

1.01

350

2252

(3007930) Methemoglobin/Hemoglobin.total in Blood

497

3404

1.48

15.06

7.7

5.3

0.95

0.89

0.43

464

3190

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

898

6822

1.35

15.02

4.0

2.6

57.92

65.88

ml/min/173m2

8.24

447

2690

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

354

2255

1.59

14.96

1.3

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

301

1843

1.65

14.94

1.7

1.4

224.78

160.57

pmol/l

1.01

294

1797

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

111

3.89

14.88

4.4

5.5

46.16

44.95

ug/min

0.04

(3033799) Differential panel - Peritoneal fluid

260

2.78

14.55

1.6

2.0

—

(3044927) Protein electrophoresis panel - Urine

163

838

1.96

14.54

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

347

2.52

14.45

1.1

1465.25

1515.49

miu/ml

0.16

347

(3011397) Hemoglobin [Presence] in Urine by Test strip

2282

19528

1.22

14.39

4.2

3.7

—

(3012516) Albumin [Mass/volume] in Urine

2847

24908

1.20

14.21

3.6

3.3

1010.55

400.86

mg/l

4.59

1884

15826

(3044007) Cell count panel - Peritoneal fluid

231

2.87

14.14

1.8

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

186

1010

1.86

14.08

1.4

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

140

692

2.04

13.97

2.2

2.4

17.86

18.68

nmol/l

0.35

132

653

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.20

13.84

1.3

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

218

2.90

13.79

2.4

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

298

2.60

13.63

1.2

—

(4281824) Cell count and differential, peritoneal fluid

172

921

1.88

13.62

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

406

2.35

13.61

2.3

1.9

—

(3016750) Collection duration of Urine

106

475

2.24

13.60

2.2

517.54

495.97

min

1.04

360

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

204

2.95

13.56

1.3

1.4

23.61

25.01

0.13

168

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.03

13.50

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1211

9728

1.28

13.42

2.0

1.7

1.54

1.46

2.81

1033

8482

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.84

13.29

6.3

3.9

2.08

2.64

mg/l

0.72

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

245

2.75

13.26

1.3

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

182

3.03

13.04

3.3

2.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.59

12.87

3.2

4.8

—

(3038026) Centromere Ab [Units/volume] in Serum

132

659

2.02

12.85

1.2

57.64

50.96

u/ml

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

302

4623

0.64

12.75

1.5

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

431

2.26

12.73

14.9

11.8

0.63

0.62

mmol/l

0.11

392

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

164

3.12

12.70

1.2

69.68

74.95

0.31

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.99

12.60

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

129

644

2.02

12.57

1.0

316.58

287.38

mg/l

2.29

112

577

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

32.04

12.55

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

124

611

2.04

12.53

1.2

65.76

41.16

mg/l

0.65

517

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

154

819

1.89

12.49

1.1

—

90.56

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

128

641

2.01

12.38

1.3

1.2

57.77

69.17

u/ml

0.26

(3027456) Digoxin [Moles/volume] in Serum or Plasma

250

1535

1.64

12.35

3.4

3.0

0.83

0.82

nmol/l

0.09

183

1164

(3023410) Appearance of Cerebral spinal fluid

154

823

1.88

12.32

3.3

1.7

—

(3021788) Differential panel - Synovial fluid

248

1523

1.64

12.24

1.7

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

239

2.69

12.20

1.2

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

163

3.08

12.19

1.2

72.29

78.43

0.52

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

128

645

2.00

12.17

1.3

1.2

24.62

39.61

u/ml

0.44

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

201

1169

1.73

12.16

1.4

1.3

0.66

1.94

nmol/l

0.66

193

1127

(3044009) aPTT.lupus sensitive (LA screen)

4.47

12.10

1.2

—

(3011985) Renin [Units/volume] in Plasma

198

1152

1.73

11.97

1.7

1.4

74.80

70.02

mu/l

0.08

176

1029

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

9.25

11.95

2.2

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

140

739

1.91

11.65

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

30.04

11.63

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

187

1081

1.74

11.58

1.3

413.14

430.05

pmol/l

0.05

154

912

(3001186) Copper [Moles/volume] in Serum or Plasma

201

2.80

11.53

1.3

1.2

17.10

16.65

umol/l

0.30

177

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

464

2.14

11.45

1.7

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

118

592

2.00

11.39

1.1

342.65

271.58

mg/l

0.50

518

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

422

2.19

11.24

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

113

561

2.03

11.24

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2938

26186

1.17

11.23

4.2

3.8

14.19

9.36

mg/mmol

4.24

1845

16512

(3032057) Clostridioides difficile [Presence] in Stool

177

2.89

11.18

2.0

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

182

1056

1.74

11.15

1.4

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

197

1173

1.69

10.99

1.4

1.3

0.15

0.27

nmol/l

1.65

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

333

2248

1.50

10.92

1.5

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

127

3.24

10.91

1.6

—

(3034426) Prothrombin time (PT)

292

2.41

10.68

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.56

10.68

1.1

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

21.46

10.66

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

178

1041

1.72

10.62

1.7

1.6

59.60

58.06

0.21

120

651

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

295

2.38

10.45

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

118

614

1.93

10.31

1.3

1.2

16.00

5.67

u/ml

0.46

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

122

642

1.91

10.30

1.2

—

(3039000) Anion gap in Blood

284

1881

1.52

10.22

10.3

7.1

11.16

11.24

mmol/l

0.12

259

1683

(3029075) Extractable nuclear Ab panel - Serum

232

2.55

10.22

1.1

—

(3018572) Chloride [Moles/volume] in Blood

284

1882

1.52

10.20

10.3

7.1

105.38

105.13

mmol/l

0.37

259

1684

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

103

513

2.02

10.20

1.9

1.5

6.82

5.96

u/l

0.63

432

(3002331) Protein [Mass/volume] in Peritoneal fluid

177

2.78

10.02

1.2

1.4

22.62

26.17

g/l

0.81

139

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

244

1576

1.56

9.85

2.0

1.7

—

(3009992) Blasts/100 cells in Bone marrow

26.02

9.80

1.5

2.2

24.77

2.80

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

433

2.09

9.80

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.98

9.75

2.0

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

898

7232

1.27

9.66

2.4

8.68

7.25

ug/l

0.67

758

6312

(3011648) Oxygen content in Venous blood

123

667

1.85

9.51

10.1

3.1

9.80

11.17

3.20

123

667

(3000492) Spirometry study

988

8062

1.25

9.49

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

124

676

1.84

9.43

2.3

2.2

704.75

649.69

0.74

461

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

129

3.03

9.35

2.0

3.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

331

2.21

9.25

1.1

1294.50

395.87

ng/l

0.40

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

410

2.08

9.22

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

232

1507

1.55

9.17

1.5

1.3

—

(3049717) Cytology report of Urine Cyto stain

430

3148

1.38

9.14

2.6

2.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

442

2.02

8.94

1.6

1.8

1.78

3.11

u/field

1.29

314

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

138

2.91

8.93

1.8

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

138

2.91

8.93

1.9

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

138

2.91

8.93

1.9

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

128

2.98

8.85

1.2

3.10

1.64

mmol/l

0.35

(3020717) Zinc [Moles/volume] in Serum or Plasma

425

2.03

8.76

1.7

1.5

20.20

24.85

umol/l

0.86

405

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

14.02

8.67

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

209

2.50

8.67

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

209

2.50

8.67

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

209

2.50

8.67

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

209

2.50

8.67

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

511

3876

1.34

8.66

1.1

52.50

188.02

titre

—

101

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.55

8.57

1.2

1.1

1.25

1.03

u/field

0.53

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.37

8.45

5.4

3.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

360

2.09

8.28

2.0

2.1

163.36

141.57

umol/l

0.13

199

(3000475) Leukocytes [#/volume] in Synovial fluid

292

2035

1.45

8.25

1.8

1.6

15029.13

13404.97

e6/l

0.27

215

1460

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

134

2.84

8.19

1.5

1.4

9.71

8.70

0.11

(3003338) MCHC [Mass/volume]

6779

70583

0.88

8.16

42.8

18.2

330.73

332.41

g/l

36.59

6741

70078

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

130

753

1.74

8.14

1.6

1.4

2.53

4.09

ug/l

2.26

642

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

113

3.02

8.13

1.5

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

363

2.07

8.12

1.1

96.10

95.15

0.07

285

(3047007) Chlamydophila sp Ab [Presence] in Serum

181

1144

1.59

8.11

1.2

—

(3019174) dRVVT (LA screen)

3.57

8.10

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

132

769

1.73

8.10

1.6

1.5

30.87

30.61

0.02

465

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.07

7.82

5.6

3.7

—

(3028707) Methadone [Presence] in Urine by Screen method

186

1198

1.56

7.71

4.6

2.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

514

3970

1.31

7.70

1.4

—

(3024316) Viscosity of Plasma

4.51

7.63

2.7

1.5

1.77

1.71

mpas

0.11

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

183

1178

1.56

7.61

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.59

7.56

1.3

1.51

1.19

ml/s/173m2

0.69

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

224

2.33

7.51

1.7

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

224

2.33

7.51

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

672

5394

1.26

7.46

1.2

104.92

144.56

iu/ml

2.02

215

1995

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

335

2.07

7.44

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

708

5725

1.25

7.38

2.4

23.18

23.33

au/ml

0.01

430

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.95

7.36

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

220

2.32

7.35

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

490

3788

1.31

7.31

2.2

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

227

2.30

7.30

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

170

1087

1.57

7.30

1.4

1.3

29.38

28.27

u/l

0.17

146

883

(44786800) Granulocytes/100 leukocytes in Body fluid

110

2.92

7.25

1.3

39.54

23.69

1.18

(3035933) Granulocytes/100 leukocytes in Blood

247

2.23

7.23

2.5

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

282

2010

1.41

7.10

1.7

1.8

4.11

4.57

iu/l

0.41

108

713

(3009542) Hematocrit [Volume Fraction] of Blood

9385

92315

1.25

7.10

49.5

20.9

39.01

40.33

28.13

8889

86450

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

328

2.05

7.09

1.5

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

510

1.83

7.06

1.4

1.3

22.86

64.76

titre

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

309

2.08

7.03

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.00

6.90

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

529

1.80

6.88

1.4

1.3

650.00

327.07

titre

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

186

1231

1.52

6.87

1.1

12.91

12.50

au/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

227

2.25

6.86

1.3

1.1

—

(3007461) Platelets [#/volume] in Blood

9388

92378

1.25

6.86

49.3

20.8

259.81

250.65

e9/l

12.12

9244

89998

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

424

1.89

6.77

1.1

1.08

1.09

u/l

0.06

196

(3014891) Appearance of Pleural fluid

109

2.85

6.77

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

105

606

1.74

6.74

2.1

2.4

—

(3045716) Anion gap in Serum or Plasma

383

1.94

6.72

1.9

2.2

8.86

9.83

mmol/l

1.79

375

(3045424) Erythrocytes [Presence] in Urine

205

1393

1.48

6.68

1.7

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

506

1.81

6.63

1.5

1.4

—

(3035941) MCH [Entitic mass]

9389

92426

1.24

6.58

49.0

20.7

30.49

30.30

11.63

9311

91149

(3024731) MCV [Entitic volume]

9389

92432

1.24

6.53

49.0

20.7

92.13

91.00

56.99

9311

91156

(3018291) Platelet Ab [Presence] in Serum

10.01

6.52

1.2

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2439

22144

1.13

6.52

1.8

1.6

1.56

1.37

mmol/l

10.05

1994

18568

(3026361) Erythrocytes [#/volume] in Blood

9389

92443

1.24

6.45

49.2

20.8

4.32

4.49

e12/l

113.79

9220

89794

(3010813) Leukocytes [#/volume] in Blood

9389

92446

1.24

6.43

49.2

20.8

7.45

6.70

e9/l

19.42

9224

89771

(3000963) Hemoglobin [Mass/volume] in Blood

9389

92462

1.24

6.31

49.5

20.9

129.82

135.40

g/l

150.33

9308

91188

(3050794) Legionella sp Ab [Presence] in Serum

3.24

6.26

1.3

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.83

6.25

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

791

6603

1.21

6.14

1.2

—

(3044941) Cell count panel - Synovial fluid

189

1289

1.48

6.09

1.6

1.4

—

(3014271) Vancomycin [Susceptibility]

404

1.86

6.09

3.2

2.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

103

1690

0.61

6.08

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

208

2.22

6.01

1.3

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

471

1.79

6.00

2.4

2.5

60.35

22.44

umol/l

0.80

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

638

5227

1.24

5.95

1.3

31.80

55.72

au/ml

2.91

287

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.52

5.87

1.1

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.37

5.85

3.1

3.5

—

(3024869) Neuronal Ab [Presence] in Serum

167

2.34

5.79

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

143

2.45

5.76

2.1

1.7

0.15

0.25

nmol/l

0.97

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.60

5.75

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.85

5.72

6.5

6.3

—

(3036180) Methadone [Presence] in Urine

343

1.90

5.65

1.7

2.4

—

(3041354) Potassium [Moles/volume] in Venous blood

149

986

1.52

5.59

3.4

2.3

4.10

4.07

mmol/l

0.41

149

974

(3035285) Chloride [Moles/volume] in Venous blood

149

986

1.52

5.59

3.4

2.3

105.30

105.57

mmol/l

0.25

149

974

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.53

5.59

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1480

0.60

5.59

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.80

5.55

1.0

1.2

19.25

20.79

u/l

0.18

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

177

2.26

5.53

1.1

—

(3022621) pH of Urine by Test strip

665

5519

1.22

5.49

3.2

3.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.06

5.48

3.8

2.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.06

5.48

2.0

63.17

60.46

0.10

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

100

606

1.66

5.45

1.8

1.6

30.33

22.62

u/ml

0.45

132

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

295

2221

1.34

5.40

2.1

1.8

39.62

41.61

nmol/l

0.66

282

2150

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.09

5.33

10.1

5.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

145

965

1.51

5.32

3.5

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

145

2.35

5.13

1.2

1.1

9.26

4.47

pmol/l

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

5.01

4.93

1.2

1.1

1.33

1.00

u/field

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.34

4.87

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

406

1.75

4.83

1.7

1.5

5.54

4.10

0.46

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

107

2.53

4.78

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

218

1599

1.37

4.78

2.3

1.9

184.58

200.43

pmol/l

1.53

210

1506

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.21

4.76

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

164

2.20

4.70

1.7

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

114

742

1.54

4.69

1.2

1.3

1.42

1.50

nmol/l

0.37

103

668

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.71

4.66

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

171

1210

1.42

4.64

1.3

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.21

4.60

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.97

4.54

5.1

10.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

170

1211

1.41

4.46

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

238

1793

1.34

4.42

4.9

2.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

149

2.22

4.42

2.9

2.1

15.95

17.72

umol/l

0.42

149

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

307

1.83

4.41

1.5

14.32

16.02

pmol/l

1.23

253

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1367

0.63

4.39

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

4.39

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

237

1.95

4.37

1.7

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1364

0.63

4.35

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

183

2.08

4.34

2.5

3.0

127.84

138.75

ng/l

0.12

(3020911) Cortisol [Moles/time] in 24 hour Urine

273

1.87

4.33

1.5

1.4

173.59

221.46

nmol/24h

0.16

273

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

151

2.19

4.29

1.8

1.6

118.62

133.03

ng/l

0.23

151

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1369

0.64

4.26

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1368

0.64

4.25

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

3.04

4.23

1.1

—

(3042517) Benzodiazepines panel - Urine

2.84

4.21

2.2

2.3

—

(3008037) Lactate [Moles/volume] in Venous blood

235

1783

1.33

4.18

4.9

3.2

1.51

1.61

mmol/l

0.83

229

1733

(3010937) Rubella virus Ab [Presence] in Serum

3.42

4.18

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

219

2882

0.75

4.12

1.9

1.7

7.42

3.77

mg/l

2.02

187

2114

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.99

4.11

1.2

1.5

0.43

0.82

0.57

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

135

2.23

4.07

1.6

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

8.00

4.05

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.45

4.03

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.34

4.03

2.3

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

4.03

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

262

2029

1.30

4.03

2.6

2.3

155.92

102.84

ug/min

0.88

144

1224

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

190

2543

0.74

4.03

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

120

820

1.47

3.98

2.4

2.1

18.19

7.83

umol/l

1.70

590

(3051387) C reactive protein [Mass/volume] in Capillary blood

233

1781

1.32

3.95

4.1

3.5

29.58

26.14

mg/l

0.78

158

1100

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

509

1.60

3.94

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

254

1.85

3.91

2.7

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

254

1.85

3.91

2.7

2.8

—

(3024263) Appearance of Synovial fluid

425

1.65

3.91

1.6

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

456

1.63

3.90

1.5

1.4

1.56

1.24

nmol/l

1.49

346

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.26

3.90

2.3

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

113

2.30

3.84

1.3

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

378

3084

1.23

3.79

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

323

1.74

3.78

2.8

2.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

384

1.67

3.75

1.7

7.49

5.27

nmol/l

0.23

315

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

115

2.26

3.70

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.00

3.68

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.79

3.68

1.1

—

(44813793) Dust mix specific IgE antibody measurement

559

1.54

3.65

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

161

1180

1.37

3.65

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1150

0.64

3.63

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

265

2089

1.28

3.60

4.0

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

772

1.46

3.59

1.4

1.3

37807.73

122343.60

e6/l

2.21

526

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

931

10485

0.88

3.59

12.4

6.9

—

(3001729) Color of Synovial fluid

2.65

3.55

1.2

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

281

2235

1.26

3.55

1.1

12.90

7.20

u/ml

0.39

263

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.39

3.55

2.2

2.5

0.36

0.59

u/field

0.95

(3005033) Fetal Nuchal fold Thickness US

1107

0.64

3.54

1.5

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

368

1.66

3.53

1.2

1.3

146.38

160.44

mmol/24h

0.63

368

(3033923) Metanephrine [Moles/time] in 24 hour Urine

171

1.99

3.52

1.2

1.1

0.67

0.69

umol/24h

0.06

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.37

3.47

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

152

1114

1.37

3.46

1.1

5.63

3.61

u/ml

0.42

495

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1111

0.65

3.44

1.5

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

273

1.76

3.43

3.5

2.8

28.65

28.38

umol/l

0.04

206

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.55

3.42

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

2.30

3.42

1.2

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.83

3.35

1.2

1.1

1.32

6.11

u/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

1.88

3.28

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

527

4520

1.18

3.16

2.5

2.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.96

3.13

2.7

2.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.25

3.12

1.2

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

7.50

3.05

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.38

3.05

1.1

1.2

2.05

1.68

umol/24h

0.55

(4200892) Spirometry reversibility

699

6154

1.15

2.98

1.6

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.47

2.95

1.2

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.54

2.95

1.9

1.8

11.71

17.74

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

655

1.44

2.92

2.2

2.0

2.85

1.85

u/field

0.72

267

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

533

1.49

2.90

1.0

1.1

6.53

11.09

iu/ml

0.72

119

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

252

1.71

2.83

2.1

9.50

9.58

mg/l

0.03

203

(3036071) Salmonella sp Ab [Titer] in Serum

269

1.68

2.77

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1916

17897

1.09

2.74

5.0

4.1

1.02

kg/l

0.36

305

2701

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.31

2.74

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

484

1.49

2.71

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.71

1.2

1.1

—

(4034850) Laboratory test

218

2707

0.80

2.70

15.8

9.8

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.18

2.66

6.5

5.0

133.40

58.79

g/mol

0.33

(3001019) Free T4 and TSH panel - Serum or Plasma

329

3913

0.84

2.65

1.6

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

107

778

1.38

2.65

4.1

4.8

47.58

74.79

u/ml

0.63

228

(3041918) Cholesterol [Moles/volume] in Pleural fluid

162

1.85

2.61

1.3

1.2

1.80

1.72

mmol/l

0.22

100

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

113

2.04

2.60

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.15

2.60

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1989

21187

0.92

2.60

4.1

4.3

22.19

21.91

0.35

955

10470

(3006442) Creatine [Moles/volume] in Serum or Plasma

555

1.44

2.59

1.9

1.5

89.61

81.68

umol/l

0.59

555

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.42

2.53

1.3

1.0

—

(3020491) Glucose [Moles/volume] in Blood

616

1.42

2.53

1.6

2.0

6.99

6.66

mmol/l

0.53

426

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.60

2.52

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

209

1680

1.25

2.52

5.3

3.3

7.25

7.60

mmol/l

1.08

204

1638

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.23

2.51

5.0

5.5

422.00

400.42

umol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

136

1.91

2.49

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

273

2262

1.21

2.48

2.9

2.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.97

2.48

1.0

1.1

0.01

0.09

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

414

1.50

2.44

1.3

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

1.71

2.36

1.4

1.5

0.47

0.39

ug/l

0.76

129

(3016879) Cocaine [Presence] in Urine

298

2504

1.20

2.35

3.8

2.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

183

1.75

2.34

2.3

1.8

2.55

2.16

ug/l

0.35

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8166

80480

1.08

2.29

5.0

4.6

6.00

5.95

mmol/l

2.79

7456

73371

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.62

2.27

1.3

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.22

2.27

1.9

3.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.2

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

2.19

2.20

2.1

2.5

234.00

504.24

umol/l

0.53

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.68

2.20

1.0

0.03

0.10

u/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

272

1.58

2.19

2.6

3.6

6.89

7.84

mg/l

0.50

221

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.24

2.17

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

316

2693

1.18

2.15

3.7

2.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

122

1.89

2.15

1.5

1.8

52.81

51.53

pmol/l

0.02

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

1.91

2.15

1.3

303.00

322.57

u/l

0.02

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

2.10

1.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.00

2.07

1.6

1.0

—

(3028300) Cannabinoids [Presence] in Urine

317

2714

1.17

2.06

3.7

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

103

1.94

2.04

1.7

2.1

—

(3034614) HLA Ag [Interpretation]

4.00

2.04

1.5

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

450

1.42

2.00

1.6

1.2

396.68

320.45

u/l

0.25

412

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

343

1.49

2.00

4.1

1.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.08

1.96

1.0

8.80

13.25

iu/ml

—

(40761535) Cells panel - Urine sediment

758

6897

1.11

1.95

4.2

3.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.35

1.94

1.3

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.45

1.92

1.2

1.0

—

(3006270) Folate [Moles/volume] in Blood

710

1.33

1.92

1.2

331.23

356.24

nmol/l

0.54

595

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

488

1.40

1.91

1.1

5.69

9.30

nmol/l

0.34

110

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.11

1.91

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

477

4232

1.13

1.91

4.3

3.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.96

1.89

1.2

1.0

0.29

0.40

u/ml

0.11

(3027008) Opiates [Presence] in Urine

314

2708

1.16

1.89

3.7

1.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.65

1.86

1.6

1.1

313.33

268.77

nmol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.86

1.86

3.7

2.3

4.19

4.41

mmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.39

1.85

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

200

2389

0.83

1.80

1.4

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.04

1.79

5.1

2.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.04

1.79

1.0

—

(3002619) Bacteria identified in Specimen by Culture

168

1.67

1.79

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.96

1.79

1.4

1.2

—

526.17

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

967

10444

0.92

1.79

4.4

4.6

31.02

32.50

4.15

717

7180

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

201

1680

1.20

1.77

2.4

1.8

1.15

0.80

nmol/l

4.47

170

1419

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.09

1.75

1.1

1.3

—

46.07

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

289

1.49

1.73

1.3

1.2

0.33

0.30

g/l

1.55

234

(40765089) Chromosome analysis panel - Blood by G-banded

201

1.59

1.73

1.0

—

(3020650) Glucose [Presence] in Urine

201

1.59

1.73

1.2

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.13

1.71

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

306

2660

1.16

1.69

3.4

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

383

1.41

1.66

2.6

2.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.50

1.66

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

343

0.58

1.65

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

188

1.60

1.65

2.4

2.3

7.55

7.66

mmol/l

0.05

115

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8273

83619

0.94

1.62

5.2

4.9

2.63

2.76

mmol/l

33.05

7615

77066

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

253

1.50

1.62

2.3

2.9

73.16

135.26

au/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

221

1.54

1.61

1.4

1.3

113.87

128.06

nmol/l

0.20

165

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

221

1.54

1.61

1.4

1.3

35.92

36.48

0.03

143

(3045683) HLA typing for celiac disease panel - Blood or Tissue

454

1.37

1.60

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.91

1.59

2.3

2.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.95

1.59

1.3

1.2

51.20

113.07

ug/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

271

1.48

1.58

1.3

1.2

104.18

110.46

0.46

238

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

191

1.57

1.56

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

552

1.32

1.54

1.8

1.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.59

1.51

1.1

1.3

1.53

1.35

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

225

1.51

1.1

0.55

2.81

u/ml

1.62

123

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

217

1.52

1.50

10.7

7.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

375

1.39

1.49

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

1.73

1.48

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.43

1.47

13.7

7.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7748

76530

1.05

1.45

6.3

5.8

39.83

39.81

mmol/mol

0.05

7145

70763

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

524

1.32

1.44

5.7

6.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1113

0.79

1.43

1.3

7.72

7.40

mmol/l

0.40

987

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

125

1.68

1.43

1.1

1.4

73.36

52.46

1.34

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1333

12611

1.07

1.39

1.5

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

247

1.46

1.37

1.3

56.47

54.13

0.13

204

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.61

1.36

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

190

1.53

1.36

11.0

7.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8063

81464

0.95

1.36

4.7

4.4

1.38

1.47

mmol/l

65.65

7412

75050

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

365

1.37

1.36

2.3

2.2

60.75

53.17

umol/l

0.72

312

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.94

1.36

2.0

2.2

—

(3049233) Organic acids panel - Urine

2.94

1.36

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

657

1.27

1.29

1.4

1.23

1.33

promille

0.25

497

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.84

1.29

1.2

1.7

47.14

41.93

umol/l

0.30

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.78

1.28

3.2

8.8

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.78

1.28

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

120

1443

0.83

1.25

1.5

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.74

1.24

2.3

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.91

1.22

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

746

6952

1.08

1.22

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

204

1.47

1.21

1.1

1.2

283.80

272.16

pmol/l

0.06

146

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1453

15236

0.95

1.20

2.9

3.0

0.75

0.76

ug/l

0.30

987

10282

(40768800) Prostate Pathology biopsy report

143

1685

0.85

1.20

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

164

1.53

1.19

1.3

—

(3007463) Buprenorphine [Presence] in Urine

2.31

1.18

10.0

5.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

186

0.54

1.16

1.0

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

588

0.75

1.14

1.0

47.16

44.36

ng/l

0.20

403

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

564

0.74

1.13

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

825

1.21

1.11

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

585

0.75

1.11

1.0

689.42

713.04

ng/l

0.16

395

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

584

0.75

1.10

1.0

321.97

332.68

ng/l

0.11

409

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.67

1.10

10.1

8.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

604

5611

1.08

1.09

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

240

2129

1.13

1.09

4.8

4.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

112

1.61

1.08

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.69

1.07

1.1

1.2

8.71

9.01

mg/l

0.06

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.27

1.03

1.4

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

203

0.59

1.03

1.3

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8137

82052

0.96

1.02

4.8

4.4

4.48

4.66

mmol/l

46.79

7559

76044

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.69

1.01

1.1

1.3

14.22

19.73

pmol/l

0.31

(3001556) Androgen free Index in Serum or Plasma

1.77

1.00

1.6

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.67

0.97

1.1

0.88

1.59

u/ml

0.31

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

816

7705

1.06

0.96

2.0

—

(3022475) Manganese [Moles/volume] in Blood

1.85

0.96

1.1

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

124

1.53

0.96

1.2

1.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.69

0.95

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

174

1530

1.14

0.94

1.2

1.1

1.75

2.07

u/ml

0.16

105

783

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

191

1.41

0.94

1.3

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.61

0.93

1.3

1.2

5.54

6.44

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

775

7320

1.06

0.92

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

929

0.83

0.91

2.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

118

1.53

0.90

1.2

1.1

71.04

77.23

ug/l

—

(37021550) Renin [Units/volume] in Plasma --upright

194

1.39

0.87

1.3

87.81

67.60

mu/l

0.21

145

(3025549) Creatine [Moles/time] in 24 hour Urine

1.72

0.86

1.3

1.4

—

(3025130) Human papilloma virus identified in Specimen

117

1010

1.16

0.84

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.94

0.84

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.76

0.83

1.2

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

860

9036

0.95

0.82

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

855

1.17

0.82

1.9

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.69

0.82

1.1

7.82

14.60

u/l

0.66

(40758358) Immune stain study

1.82

0.79

1.0

—

(1002224) Polysomnography panel

302

3283

0.92

0.78

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

142

1255

1.13

0.76

1.1

2.58

1.37

u/ml

0.63

637

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.74

1.1

1.5

524.11

322.37

umol/24h

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.61

0.72

1.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.92

0.70

1.0

1.2

—

mmol/l

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.92

0.70

1.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

377

0.77

0.70

1.1

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

427

1.22

0.69

2.2

2.1

118.87

161.38

ug/min

0.20

(3008898) HLA-B27 [Presence]

290

2681

1.08

0.68

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

109

1238

0.88

0.66

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.79

0.66

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

451

4248

1.06

0.64

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

151

1358

1.11

0.64

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

159

1436

1.11

0.63

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.67

0.61

1.2

1.3

309.74

436.05

nmol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

100

881

1.14

0.60

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

280

1.25

0.60

1.7

1.8

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

12181.25

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.56

0.55

1.2

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

788

1.13

0.52

3.9

2.9

101.89

58.97

mg/l

0.59

584

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

136

1.32

0.49

1.3

1.1

3.09

7.30

u/ml

0.37

101

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

326

1.20

0.48

3.4

2.5

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.49

0.47

1.0

1.99

3.31

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

885

0.89

0.44

1.1

1.0

0.25

0.31

u/ml

0.13

266

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.44

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

257

2727

0.94

0.43

1.9

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

214

2284

0.94

0.43

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.43

0.41

1.6

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

258

1.20

0.41

1.4

1.2

41.06

38.39

g/l

0.50

137

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.41

1.8

1.2

1.72

1.86

mg/l

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

3.72

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

407

1.16

0.41

1.1

1.0

0.32

1.24

u/ml

0.72

114

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

405

4232

0.96

0.40

1.8

1.9

—

(3022689) Creatine [Moles/volume] in Urine

241

1.20

0.40

1.7

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

506

0.87

0.38

1.1

1.3

1.48

1.57

g/l

0.98

506

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

927

0.91

0.38

1.5

—

(3000285) Sodium [Moles/volume] in Blood

116

1.29

0.37

1.2

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

207

1.21

0.36

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

115

1063

1.08

0.35

2.8

2.1

27.77

25.19

mg/l

0.15

280

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.28

0.32

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

248

1.17

0.31

1.3

1.5

9.68

8.75

ug/l

0.49

248

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

279

2671

1.05

0.30

1.6

1.4

—

(3015183) Erythrocyte sedimentation rate

372

1.13

0.29

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

383

1.12

0.28

11.1

10.9

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.29

0.28

1.0

0.19

1.05

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

215

0.84

0.27

1.1

1.0

6.43

11.83

u/ml

1.35

123

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

328

1.13

0.26

1.3

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

159

1.20

0.26

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

159

1.20

0.26

3.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

416

0.89

0.26

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.69

0.26

1.0

3.54

3.23

kpa

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2680

26534

1.01

0.24

4.8

5.0

3.82

3.22

ug/l

0.47

2356

23818

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

103

1096

0.94

0.24

1.8

1.7

—

(3008607) Semen analysis panel

1.32

0.23

1.0

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

379

0.90

0.22

1.1

8.42

4.82

u/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

146

0.82

0.22

1.2

1.1

79.92

56.23

u/ml

0.51

138

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

1.22

0.21

1.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

145

0.83

0.21

3.6

6.5

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.25

0.20

1.4

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.20

0.0

2.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.13

0.18

1.0

1.1

4.83

2.79

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

453

1.08

0.18

1.1

2.11

2.39

u/ml

0.07

151

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

325

3337

0.97

0.18

1.7

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

147

1.16

0.18

10.5

7.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

103

983

1.05

0.16

1.1

1.86

3.82

u/ml

1.77

405

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.14

0.16

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

149

1.14

0.15

1.6

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

1054

1.04

0.15

1.1

6.18

3.52

u/ml

0.50

504

(42870560) Thyrotropin [Units/volume] in Cord blood

1.10

0.15

1.0

7.75

8.34

mu/l

—

(3028717) Thiamine [Mass/volume] in Blood

1.18

0.14

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

0.80

0.13

1.4

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.14

0.10

1.0

0.36

8.89

u/ml

—

(3026470) Cobalt [Mass/volume] in Blood

555

0.95

0.10

2.0

1.9

4.47

3.63

ug/l

0.47

504

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

9.32

10.64

u/ml

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.09

0.09

1.2

1.0

—

(1761868) Lipid panel - Serum or Plasma

2863

28744

0.99

0.09

3.2

2.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7880

78696

1.01

0.08

4.4

4.0

1.40

1.30

mmol/l

22.40

7207

71895

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

127

1301

0.98

0.08

1.1

90.07

7747.52

iu/ml

0.55

313

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.82

0.08

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.83

0.07

1.0

—

-2.56

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.83

0.07

1.0

7.52

7.42

kpa

—

(3006598) pH of Arterial cord blood

0.83

0.07

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

131

1338

0.98

0.07

1.1

0.46

1.05

u/ml

1.84

582

(3025577) Chromium [Mass/volume] in Blood

539

0.96

0.07

2.0

2.84

2.55

ug/l

0.30

446

(3006462) Nitrate [Presence] in Urine

414

1.04

0.06

2.6

3.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

573

1.03

0.05

1.7

1.3

605.03

183.89

pmol/l

0.47

573

(3003888) Timothy IgE Ab [Units/volume] in Serum

141

1387

1.02

0.05

1.1

2.73

4.77

u/ml

1.96

711

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

161

0.93

0.05

1.2

1.3

0.75

100.78

mg/l

—

121

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

110

1.09

0.05

1.1

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

459

1.02

0.03

1.1

10.59

1.67

u/ml

0.46

123

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

142

1.06

0.02

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

123

1.06

0.01

1.2

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

105

1.05

0.00

3.8

1.4

112.00

135.77

titre

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.91

-0.00

1.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.1

—

39.55

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.1

—

69.11

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.95

-0.00

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

16.14

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.2

—

15.00

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_BLOODOTHER and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_BLOODOTHER	3.195 [2.89, 3.53]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 7704 out of 25972 females with D3_BLOODOTHER died.

Males

Parameter	HR [95% CI]	p-value
D3_BLOODOTHER	3.295 [2.94, 3.69]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 7471 out of 21167 males with D3_BLOODOTHER died.

Mortality risk

Mortality risk for people of age

years, who have D3_BLOODOTHER.

N-year risk	Females	Males
1	0.244%	0.68%
5	1.523%	3.577%
10	3.825%	8.513%
15	7.013%	16.125%
20	12.503%	26.374%

Relationships between endpoints

↥

Index endpoint: D3_BLOODOTHER – Other diseases of blood and blood-forming organs, wide

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of blood and blood-forming organs, wide

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints